<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="haematol"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC3186311/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186311/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Haematologica"><meta name="citation_title" content="Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial"><meta name="citation_authors" content="Rachel Wade, Maria Chiara Di Bernardo, Sue Richards, Davide Rossi, Dalemari Crowther-Swanepoel, Gianluca Gaidano, David G. Oscier, Daniel Catovsky, Richard S. Houlston"><meta name="citation_date" content="October 2011"><meta name="citation_issue" content="10"><meta name="citation_volume" content="96"><meta name="citation_firstpage" content="1496"><meta name="citation_doi" content="10.3324/haematol.2011.043471"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3186311/?report=abstract"><meta name="citation_pmid" content="21659360"><meta name="DC.Title" content="Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Ferrata Storti Foundation"><meta name="DC.Contributor" content="Rachel Wade"><meta name="DC.Contributor" content="Maria Chiara Di Bernardo"><meta name="DC.Contributor" content="Sue Richards"><meta name="DC.Contributor" content="Davide Rossi"><meta name="DC.Contributor" content="Dalemari Crowther-Swanepoel"><meta name="DC.Contributor" content="Gianluca Gaidano"><meta name="DC.Contributor" content="David G. Oscier"><meta name="DC.Contributor" content="Daniel Catovsky"><meta name="DC.Contributor" content="Richard S. Houlston"><meta name="DC.Date" content="2011 Oct"><meta name="DC.Identifier" content="10.3324/haematol.2011.043471"><meta name="DC.Language" content="en"><meta property="og:title" content="Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial"><meta property="og:type" content="article"><meta property="og:description" content="There is variability in the outcome of patients with chronic lymphocytic leukemia with apparently the same stage of disease. Identifying genetic variants that influence patients’ outcome and response to treatment may provide important insights ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186311/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-haematol.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3186311/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3186311/pdf/0961496.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE89F792DD524231000000000689043F.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3186311%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/820/">Haematologica</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/200717/">v.96(10); 2011 Oct</a></li><li class="accid">PMC3186311</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-haematol.gif" alt="Logo of haematol" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.haematologica.org/" target="pmc_ext" ref="reftype=publisher&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Haematologica</a></span>. 2011 Oct; 96(10): 1496–1503. </span></div><div><span class="fm-vol-iss-date">Published online 2011 Jun 9. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.3324%2Fhaematol.2011.043471" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.3324/haematol.2011.043471</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3186311</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/21659360">21659360</a></div></div></div></div><h1 class="content-title">Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Wade%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360" class="affpopup" co-rid="_co_idm140613480300272" co-class="co-affbox">Rachel Wade</a>,<sup>1</sup> <a href="/pubmed/?term=Di%20Bernardo%20MC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360" class="affpopup" co-rid="_co_idm140613473421408" co-class="co-affbox">Maria Chiara Di Bernardo</a>,<sup>2</sup> <a href="/pubmed/?term=Richards%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360" class="affpopup" co-rid="_co_idm140613478911168" co-class="co-affbox">Sue Richards</a>,<sup>1</sup> <a href="/pubmed/?term=Rossi%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360" class="affpopup" co-rid="_co_idm140613474895280" co-class="co-affbox">Davide Rossi</a>,<sup>3</sup> <a href="/pubmed/?term=Crowther-Swanepoel%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360" class="affpopup" co-rid="_co_idm140613474893168" co-class="co-affbox">Dalemari Crowther-Swanepoel</a>,<sup>2</sup> <a href="/pubmed/?term=Gaidano%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360" class="affpopup" co-rid="_co_idm140613476501088" co-class="co-affbox">Gianluca Gaidano</a>,<sup>3</sup> <a href="/pubmed/?term=Oscier%20DG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360" class="affpopup" co-rid="_co_idm140613483588576" co-class="co-affbox">David G. Oscier</a>,<sup>4</sup> <a href="/pubmed/?term=Catovsky%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360" class="affpopup" co-rid="_co_idm140613514412896" co-class="co-affbox">Daniel Catovsky</a>,<sup>5</sup> and  <a href="/pubmed/?term=Houlston%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360" class="affpopup" co-rid="_co_idm140613474245152" co-class="co-affbox">Richard S. Houlston</a><sup>2</sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140613480300272"><h3 class="no_margin">Rachel Wade</h3><p><sup>1</sup>Clinical Trial Service Unit, University of Oxford, Oxford, UK</p><div>Find articles by <a href="/pubmed/?term=Wade%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360">Rachel Wade</a></div></div><div id="_co_idm140613473421408"><h3 class="no_margin">Maria Chiara Di Bernardo</h3><p><sup>2</sup>Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK</p><div>Find articles by <a href="/pubmed/?term=Di%20Bernardo%20MC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360">Maria Chiara Di Bernardo</a></div></div><div id="_co_idm140613478911168"><h3 class="no_margin">Sue Richards</h3><p><sup>1</sup>Clinical Trial Service Unit, University of Oxford, Oxford, UK</p><div>Find articles by <a href="/pubmed/?term=Richards%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360">Sue Richards</a></div></div><div id="_co_idm140613474895280"><h3 class="no_margin">Davide Rossi</h3><p><sup>3</sup>Division of Hematology, Department of Clinical and Experimental Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy</p><div>Find articles by <a href="/pubmed/?term=Rossi%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360">Davide Rossi</a></div></div><div id="_co_idm140613474893168"><h3 class="no_margin">Dalemari Crowther-Swanepoel</h3><p><sup>2</sup>Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK</p><div>Find articles by <a href="/pubmed/?term=Crowther-Swanepoel%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360">Dalemari Crowther-Swanepoel</a></div></div><div id="_co_idm140613476501088"><h3 class="no_margin">Gianluca Gaidano</h3><p><sup>3</sup>Division of Hematology, Department of Clinical and Experimental Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy</p><div>Find articles by <a href="/pubmed/?term=Gaidano%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360">Gianluca Gaidano</a></div></div><div id="_co_idm140613483588576"><h3 class="no_margin">David G. Oscier</h3><p><sup>4</sup>Department of Haematology, Royal Bournemouth Hospital, Bournemouth, Dorset, UK</p><div>Find articles by <a href="/pubmed/?term=Oscier%20DG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360">David G. Oscier</a></div></div><div id="_co_idm140613514412896"><h3 class="no_margin">Daniel Catovsky</h3><p><sup>5</sup>Section of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK</p><div>Find articles by <a href="/pubmed/?term=Catovsky%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360">Daniel Catovsky</a></div></div><div id="_co_idm140613474245152"><h3 class="no_margin">Richard S. Houlston</h3><p><sup>2</sup>Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK</p><div>Find articles by <a href="/pubmed/?term=Houlston%20RS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21659360">Richard S. Houlston</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140613514334336_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140613514334336_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140613514334336_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140613514334336_ai" style="display:none"><div class="fm-affl" id="af1-0961496" lang="en"><sup>1</sup>Clinical Trial Service Unit, University of Oxford, Oxford, UK</div><div class="fm-affl" id="af2-0961496" lang="en"><sup>2</sup>Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, UK</div><div class="fm-affl" id="af3-0961496" lang="en"><sup>3</sup>Division of Hematology, Department of Clinical and Experimental Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy</div><div class="fm-affl" id="af4-0961496" lang="en"><sup>4</sup>Department of Haematology, Royal Bournemouth Hospital, Bournemouth, Dorset, UK</div><div class="fm-affl" id="af5-0961496" lang="en"><sup>5</sup>Section of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK</div><div id="c1-0961496">Correspondence: Richard S. Houlston, Section of Cancer Genetics, Institute of Cancer Research, Sutton, Surrey, SM2 5NG, UK., Phone: international +44.020.87224175., Fax: international +44.020.87224059., E-mail: <a href="mailto:dev@null" data-email="ku.ca.rci@notsluoh.drahcir" class="oemail">ku.ca.rci@notsluoh.drahcir</a></div><div id="idm140613474040736">RW and MCDB contributed equally to this manuscript.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140613514334336_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2011 Mar 8; Revised 2011 May 5; Accepted 2011 May 31.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140613514334336_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © Ferrata Storti Foundation</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC3186311/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140613482423696" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140613482423696title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p2" class="p p-first-last">There is variability in the outcome of patients with chronic lymphocytic leukemia with apparently the same stage of disease. Identifying genetic variants that influence patients’ outcome and response to treatment may provide important insights into the biology of the disease.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Design and Methods</h3><p id="__p3" class="p p-first-last">We investigated the possibility that genetic variation influences outcome by conducting a genome-wide analysis of 346,831 single nucleotide polymorphisms in 356 patients entered into a phase III trial comparing the efficacy of fludarabine, chlorambucil, and fludarabine with cyclophosphamide as first-line treatment. Genotypes were linked to individual patients’ outcome data and response to chemotherapy. The association between genotype and progression-free survival was assessed by Cox regression analysis adjusting for treatment and clinicopathology.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p4" class="p p-first-last">The strongest associations were shown for rs1949733 (<em>ACOX3; P</em>=8.22x10-7), rs1342899 (<em>P</em>=7.72x10<sup>−7</sup>) and rs11158493 (<em>PPP2R5E; P</em>=8.50×10<sup>−7</sup>). In addition, the 52 single nucleotide polymorphisms associated at <em>P</em>&lt;10<sup>−4</sup> included rs438034 (<em>CENPF; P</em>=4.86×10<sup>−6</sup>), previously correlated with cancer progression, and rs2255235 (<em>B2M; P</em>=3.10×10<sup>−5</sup>) and rs2064501 (<em>IL22RA2; P</em>=4.81×10<sup>−5</sup>) which map to B-cell genes.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusions</h3><p id="__p5" class="p p-first-last">Our findings provide evidence that genetic variation is a determinant of progression-free survival of patients with chronic lymphocytic leukemia. Specific associations warrant further analyses. <em>(<a href="http://Clinicaltrials.gov" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">Clinicaltrials.gov</a> identifier: <a id="__tag_545222792" class="tag_hotlink" href="https://clinicaltrials.gov/ct2/show/NCT00004218" ref="reftype=extlink-clinical-trial&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CBody&amp;TO=External%7CResource%7CClinical%20Trials%7CClinicalTrials.gov"><span class="tag-json" style="display:none">{"type":"clinical-trial","attrs":{"text":"NCT00004218","term_id":"NCT00004218"}}</span>NCT00004218</a>)</em></p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">chronic lymphocytic leukemia, SNP, chlorambucil, fludarabine, cyclophosphamide</span></div></div><div id="__sec5" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec5title">Introduction</h2><p id="__p6" class="p p-first">Chronic lymphocytic leukemia (CLL) is the commonest lymphoid malignancy in Western populations.<sup><a href="#b1-0961496" rid="b1-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857524" role="button" aria-expanded="false" aria-haspopup="true">1</a></sup><sup>,</sup><sup><a href="#b2-0961496" rid="b2-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857539" role="button" aria-expanded="false" aria-haspopup="true">2</a></sup> While staging systems (Binet, Rai) are clinically useful for predicting prognosis and treatment requirements in CLL<sup><a href="#b3-0961496" rid="b3-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857549" role="button" aria-expanded="false" aria-haspopup="true">3</a></sup> there is variability in the outcome of patients who apparently have the same stage of disease. More precise assessment of prognosis would, therefore, be beneficial in the choice of specific therapeutic options, while assessment of the likelihood of response and adverse reactions to chemotherapeutic treatments would allow patient-tailored decisions on drug selection and consequent improvements in patients’ outlook.</p><p id="__p7">Molecular markers such as immunoglobulin heavy-chain variable region (<em>IGHV</em>) mutational status have been shown to greatly assist in defining patients’ prognosis.<sup><a href="#b4-0961496" rid="b4-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857547" role="button" aria-expanded="false" aria-haspopup="true">4</a></sup><sup>–</sup><sup><a href="#b6-0961496" rid="b6-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857542" role="button" aria-expanded="false" aria-haspopup="true">6</a></sup> In addition, genetic variability between patients may also contribute to outcome. To date most searches for polymorphic markers associated with patients’ prognosis have been formulated on an “educated guess”; however, without a full understanding of the biology of CLL, definition of what constitutes a “suitable” candidate gene is problematic. This makes agnostic “genome-wide” searches an attractive proposition. Many of the previous candidate studies were based on small numbers of patients ascertained outside the context of any clinical trial. In addition to having limited power such studies are prone to bias as a consequence of survivorship and other confounders, especially when based on retrospectively ascertained patients who did not receive uniform treatment.</p><p id="__p8" class="p p-last">We have recently conducted a genome-wide association study of CLL searching for susceptibility alleles for the disease.<sup><a href="#b7-0961496" rid="b7-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857522" role="button" aria-expanded="false" aria-haspopup="true">7</a></sup><sup>,</sup><sup><a href="#b8-0961496" rid="b8-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_617299259" role="button" aria-expanded="false" aria-haspopup="true">8</a></sup> Three hundred and fifty-six of the patients genotyped in this study were participants in a phase III clinical trial. Linking genetic data to information on clinical outcome for these patients allowed us to search for novel genetic variants influencing the clinical behavior of CLL.</p></div><div id="__sec6" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec6title">Design and Methods</h2><div id="__sec7" class="sec sec-first"><h3 id="__sec7title">Study population</h3><p id="__p9" class="p p-first-last">We made use of a genome-wide association study based on CLL patients entered in the UK Leukemia Research Fund CLL-4 trial. Comprehensive details about the design and conduct of the trial, including drug dosages, have been published elsewhere.<sup><a href="#b9-0961496" rid="b9-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857534" role="button" aria-expanded="false" aria-haspopup="true">9</a></sup> Briefly, CLL-4 was a randomized phase III trial established to compare the efficacy of fludarabine, chlorambucil, and the combination of fludarabine plus cyclophosphamide as a first-line treatment for Binet stages B, C and A-progressive CLL. Age was not a criterion for entry into the study. Of the 777 patients entered into the trial the current analysis is based on a random subset of 356 Caucasians who had blood samples taken for clinical diagnostic purposes and cell marker studies at participating centers. <em>IGHV</em> mutational status was determined according to BIOMED-2 protocols, using commercial reagents (<em>InVivoScribe</em> Technologies, San Diego, USA), as described previously. Clonality was assessed by size discrimination of polymerase chain reaction (PCR) products using semi-automated ABI3730xl/ABI3700 sequencers in conjunction with Genescan software (Applied Biosystems, Foster City, USA). Sequences obtained were submitted to the IMGT/V-QUEST online database. In accordance with published criteria, sequences with a germline identity of 98% or more were classified as unmutated, and those displaying less than 98% identity as mutated.</p></div><div id="__sec8" class="sec"><h3 id="__sec8title">Subjects for the replication phase</h3><p id="__p10" class="p p-first">To validate selected associations of single nucleotide polymorphisms (SNP), we made use of outcome data on 380 patients attending the Division of Hematology of the Amedeo Avogadro University of Eastern Piedmont between January 1985 and September 2009.</p><p id="__p11" class="p p-last">Ethical approval for the study was obtained from the relevant Research Ethics Committees in each study center and the study was conducted in accordance with the tenets of the Declaration of Helsinki.</p></div><div id="__sec9" class="sec"><h3 id="__sec9title">Genotyping</h3><p id="__p12" class="p p-first-last">DNA was extracted by a standard saltlysis protocol from venous blood samples collected into EDTA. Overall, 346,831 tagging SNP were genotyped using Illumina Human CNV370-Duo BeadChips (Illumina, San Diego, CA, USA) according to the manufacturer’s protocols, as described previously.<sup><a href="#b7-0961496" rid="b7-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857543" role="button" aria-expanded="false" aria-haspopup="true">7</a></sup> Subsequent genotyping was conducted by competitive allele-specific PCR KASPar chemistry (KBiosciences Ltd, Hertfordshire, UK; <em><a href="http://www.kbio-science.co.uk/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.kbio-science.co.uk/</a></em>); primer sequences and conditions are available on request. As a quality control, we included samples of known genotype and replicates in each assay. A concordance of 99.9% was obtained for both sets of genotyping.</p></div><div id="__sec10" class="sec"><h3 id="__sec10title">Statistical methods</h3><p id="__p13" class="p p-first-last">Progression-free survival was the primary end-point of the analysis. The response recorded for each patient was the best achieved at any time due to first-line treatment. Progression-free survival was defined as the time from the date of randomization to relapse needing further therapy, progression or death from any cause. For non-responders and progressive disease, the date of progression was when no response or progressive disease was recorded. Data on age at diagnosis, Binet stage at diagnosis, sex and treatment were available for all patients, and <em>IGHV</em> mutation status was available for a subset of patients, enabling us to examine the significance of each SNP association conditional on these covariates. Cox-regression analysis was used to estimate genotype-specific hazard ratios (HR) and 95% confidence intervals (CI), adjusting for all covariates. For each SNP genotype the hazard ratios were generated using common allele homozygotes as the reference group. The <em>P</em>-values presented correspond to the significance of a test difference, trend test, across the three genotype groups (common allele homozygote, heterozygote, rare allele homozygote). For those SNP for which five or fewer minor allele homozygotes were observed, minor allele homozygote genotypes were combined with heterozygotes. If this combined frequency was still five or less then the SNP was removed from the analysis. Hazard ratios, 95% confidence intervals and associated <em>P</em> values under both dominant and recessive models were also generated. To assess the distribution of test statistics, we generated quantile-quantile (Q-Q) plots. Progression-free survival curves were plotted using Kaplan-Meier estimates. All statistical analyses were undertaken using R Version 2.7.0 and PLINK.</p></div><div id="__sec11" class="sec"><h3 id="__sec11title">Bioinformatics</h3><p id="__p14" class="p p-first-last">To predict the impact of missense variants on protein function, we applied two <em>in silico</em> algorithms, polymorphism phenotyping (PolyPhen)<sup><a href="#b10-0961496" rid="b10-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857540" role="button" aria-expanded="false" aria-haspopup="true">10</a></sup> and sifting intolerant from tolerant (SIFT).<sup><a href="#b11-0961496" rid="b11-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857523" role="button" aria-expanded="false" aria-haspopup="true">11</a></sup> PolyPhen predicts the functional impact of amino acid changes by considering evolutionary conservation, physicochemical differences, and the proximity of the substitution to predicted functional domains and/or structural features. SIFT predicts the functional importance of amino acid substitutions based on the alignment of orthologous and/or paralogous protein sequences. SIFT and PolyPhen scores were classified as intolerant, potentially intolerant, borderline, or tolerant and probably damaging, possibly damaging, potentially damaging, borderline, or benign, respectively, according to the classifications proposed by Xi <em>et al.</em><sup><a href="#b12-0961496" rid="b12-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857541" role="button" aria-expanded="false" aria-haspopup="true">12</a></sup> and Ng and Henikoff.<sup><a href="#b11-0961496" rid="b11-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857544" role="button" aria-expanded="false" aria-haspopup="true">11</a></sup></p></div><div id="__sec12" class="sec sec-last"><h3 id="__sec12title">Relationship between single nucleotide polymorphism genotype and expression levels</h3><p id="__p15" class="p p-first">To examine for a relationship between SNP genotype and gene expression we made use of publicly available expression data generated from an analysis of 90 Caucasian-derived Epstein-Barr virus–transformed lymphoblastoid cell lines using Sentrix Human-6 Expression BeadChips (Illumina, San Diego, USA).<sup><a href="#b13-0961496" rid="b13-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857531" role="button" aria-expanded="false" aria-haspopup="true">13</a></sup><sup>,</sup><sup><a href="#b14-0961496" rid="b14-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857526" role="button" aria-expanded="false" aria-haspopup="true">14</a></sup> Online data were recovered using WGAViewer version 1.25 software. Differences in the distribution of levels of mRNA expression between SNP genotypes were compared using an extension of Wilcoxon’s rank-sum test for trends across ordered groups.<sup><a href="#b15-0961496" rid="b15-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857538" role="button" aria-expanded="false" aria-haspopup="true">15</a></sup></p></div></div><div id="__sec13" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec13title">Results</h2><div id="__sec14" class="sec sec-first"><h3 id="__sec14title">Patients’ characteristics</h3><p id="__p17" class="p p-first-last">A third of the patients had been diagnosed with CLL before 60 years old and approximately two-thirds had presented with stage B or C disease. The median follow-up time for patients was 78 months with follow-up to October 31, 2008. Forty-nine percent of the cohort died. Only drug therapy significantly influenced progression-free survival. Specifically, the combination of fludarabine and cyclophosphamide as drug therapy was significantly associated with a more favorable prognosis (<a href="/pmc/articles/PMC3186311/table/t1-0961496/" target="table" class="fig-table-link figpopup" rid-figpopup="t1-0961496" rid-ob="ob-t1-0961496" co-legend-rid=""><span>Table 1</span></a>). For 305 (86%) of the 356 patients we had information on <em>IGHV</em> mutation status. As in the parent trial this covariate was prognostically important, being highly predictive of progression-free survival (<em>P</em>&lt;0.0001). There was no difference in the demographics, treatment, and follow-up characteristics of the 356 cases genotyped in this study compared to those of the patients entered into CLL-4 but who were excluded from this analysis (<em>Online Supplementary Table S1</em>). It is, therefore, unlikely that any spurious biases have influenced our findings. The observation that conventional staging and other markers of prognosis were equally predictive of survival in the complete cohort of patients and in the subgroup analyzed provides further evidence that sub-selection of the genotyped cases is unlikely to have biased the overall findings of the study.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="t1-0961496"><h3>Table 1.</h3><!--caption a7--><div class="caption"><p id="__p16">Relationship between treatment, stage, age and sex, and progression-free survival in the patients genotyped.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140613482196112" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3186311_961496.tab1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 961496.tab1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3186311/bin/961496.tab1.jpg"></a></div><div id="largeobj_idm140613482196112" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3186311/table/t1-0961496/?report=objectonly">Open in a separate window</a></div></div></div><div id="__sec15" class="sec"><h3 id="__sec15title">Genotyping quality control</h3><p id="__p18" class="p p-first-last">SNP call rates per sample were greater than 97.8% in patients. Of the 346,831 SNP submitted for analysis, 345,665 were satisfactorily genotyped (99.7%), with mean individual SNP call rates of 99.6%. Of the 345,665 SNP loci that were satisfactorily genotyped, 7,165 were fixed in all patients’ samples and 12,115 were either observed at sub-polymorphic frequencies (i.e. having a minor allele frequency &lt;1%) or departed from Hardy-Weinberg equilibrium (<em>P</em>≤10<sup>−5</sup>), and were, therefore, excluded from all analyses. Of the 326,385 remaining SNP to be analyzed, cell counts of minor allele genotypes were sufficiently infrequent to exclude 65,909 from recessive model analyses.</p></div><div id="__sec16" class="sec"><h3 id="__sec16title">Association between single nucleotide polymorphisms and progression-free survival</h3><p id="__p19" class="p p-first">We examined the overall effect of patients’ genotype on progression-free survival by generating a Q-Q plot of observed test statistics compared to the mean of the corresponding expected values and calculating an overdispersion factor, λ.<sup><a href="#b16-0961496" rid="b16-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857548" role="button" aria-expanded="false" aria-haspopup="true">16</a></sup> After adjustment for sex, age, stage of disease at presentation and drug regime, a Q-Q plot of test statistics of the association between SNP genotype and progression-free survival showed a significant deviation from the expected distribution with λ=1.071616 (95% CI: 1.071570–1.071661, <a href="/pmc/articles/PMC3186311/figure/f1-0961496/" target="figure" class="fig-table-link figpopup" rid-figpopup="f1-0961496" rid-ob="ob-f1-0961496" co-legend-rid="lgnd_f1-0961496"><span>Figure 1</span></a>); this inflation reflects an over-representation of test statistics, indicative of an association between genotype and progression-free survival globally.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="f1-0961496" co-legend-rid="lgnd_f1-0961496"><a href="/pmc/articles/PMC3186311/figure/f1-0961496/" target="figure" rid-figpopup="f1-0961496" rid-ob="ob-f1-0961496"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140613472798496" class="figure"><a href="/pmc/articles/PMC3186311/figure/f1-0961496/" target="figure" rid-figpopup="f1-0961496" rid-ob="ob-f1-0961496"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3186311_961496.fig1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 961496.fig1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3186311/bin/961496.fig1.jpg"></a></div><div id="largeobj_idm140613472798496" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3186311/figure/f1-0961496/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_f1-0961496"><div><a class="figpopup" href="/pmc/articles/PMC3186311/figure/f1-0961496/" target="figure" rid-figpopup="f1-0961496" rid-ob="ob-f1-0961496">Figure 1.</a></div><!--caption a7--><div class="caption"><p id="__p20">Quantile-quantile plot for progression-free survival from the genome-wide association study. The dotted line represents the observed <em>P</em> values. The solid line represents the expected line under the null distribution.</p></div></div></div><p id="__p21">Fifty-two SNP (mapping to 38 genomic regions) showed an association with progression-free survival with a <em>P</em> value of 10<sup>−4</sup> or less, significantly greater than that expected simply by chance (<em>P</em>&lt;0.05; <a href="/pmc/articles/PMC3186311/table/t2-0961496/" target="table" class="fig-table-link figpopup" rid-figpopup="t2-0961496" rid-ob="ob-t2-0961496" co-legend-rid=""><span>Table 2</span></a>). Three of the 52 associations were of borderline statistical significance, when Bonferroni’s correction was applied (<em>i.e. P</em>≤2.0×10<sup>−7</sup>): rs1949733 (<em>P</em>=8.22×10<sup>−7</sup>), rs1342899 (<em>P</em>=7.72×10<sup>−7</sup>) and rs11158493 (<em>P</em>=8.50×10<sup>−7</sup>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="t2-0961496"><h3>Table 2.</h3><!--caption a7--><div class="caption"><p id="__p31">SNP showing significant (at a threshold of 10<sup>−4</sup>) genotypic association with progression-free survival.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140613515155792" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3186311_961496.tab2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 961496.tab2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3186311/bin/961496.tab2.jpg"></a></div><div id="largeobj_idm140613515155792" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3186311/table/t2-0961496/?report=objectonly">Open in a separate window</a></div></div><p id="__p22">For 305 (86%) of the 356 patients, we had information on <em>IGHV</em> mutational status, allowing us to evaluate the impact of polymorphic variation adjusting for this clinically important prognostic marker. In a multivariate analysis 13 of the 52 SNP retained significance at the 10<sup>−4</sup> threshold, and a further 26 showed evidence of an association with progression-free survival at the 10<sup>−3</sup> threshold: these are annotated using asterisks in <a href="/pmc/articles/PMC3186311/table/t2-0961496/" target="table" class="fig-table-link figpopup" rid-figpopup="t2-0961496" rid-ob="ob-t2-0961496" co-legend-rid=""><span>Table 2</span></a>; all SNP retained conventional significance (<em>P</em>&lt;0.05).</p><p id="__p23">For purposes of clarity we have restricted our commentary here to the major loci defined by the 52 SNP. Of these 52 SNP, rs438034 has previously been reported to influence the prognosis of patients with breast cancer<sup><a href="#b17-0961496" rid="b17-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857529" role="button" aria-expanded="false" aria-haspopup="true">17</a></sup> and a further three SNP tag genes with a known or presumptive biological role in B-cell biology or tumor behavior (<a href="/pmc/articles/PMC3186311/table/t2-0961496/" target="table" class="fig-table-link figpopup" rid-figpopup="t2-0961496" rid-ob="ob-t2-0961496" co-legend-rid=""><span>Table 2</span></a>).</p><p id="__p24">Centromeric protein F (<em>CENPF</em>, MIM 600236) is involved in the maintenance of chromosomal stability. Under the Cox proportional hazards model homozygosity for <em>CENPF</em> 2943T (rs438034) was associated with a poorer progression-free survival (HR=1.88; 95% CI: 1.44–2.46; <em>P</em>=3.10×10<sup>−6</sup>). The 5-year progression-free survival for T homozygotes was 8.9% (95% CI: 4.3–18.3%) compared to 19.9% (95% CI: 15.8–25.3%) for heterozygotes and C homozygotes (<a href="/pmc/articles/PMC3186311/figure/f2-0961496/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-0961496" rid-ob="ob-f2-0961496" co-legend-rid="lgnd_f2-0961496"><span>Figure 2A</span></a>). An association between progression-free survival and the <em>CENPF</em> SNP rs3748697 (N2396D) was also shown (HR=0.64, 95% CI: 0.49–0.84; <em>P</em>=1.46×10<sup>−5</sup>; <a href="/pmc/articles/PMC3186311/table/t2-0961496/" target="table" class="fig-table-link figpopup" rid-figpopup="t2-0961496" rid-ob="ob-t2-0961496" co-legend-rid=""><span>Table 2</span></a>). rs438034 and rs3748697 are highly correlated, with LD metrics: r<sup>2</sup> =0.934, D′=0.967.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="f2-0961496" co-legend-rid="lgnd_f2-0961496"><a href="/pmc/articles/PMC3186311/figure/f2-0961496/" target="figure" rid-figpopup="f2-0961496" rid-ob="ob-f2-0961496"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140613472122176" class="figure"><a href="/pmc/articles/PMC3186311/figure/f2-0961496/" target="figure" rid-figpopup="f2-0961496" rid-ob="ob-f2-0961496"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3186311_961496.fig2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 961496.fig2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3186311/bin/961496.fig2.jpg"></a></div><div id="largeobj_idm140613472122176" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC3186311/figure/f2-0961496/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_f2-0961496"><div><a class="figpopup" href="/pmc/articles/PMC3186311/figure/f2-0961496/" target="figure" rid-figpopup="f2-0961496" rid-ob="ob-f2-0961496">Figure 2.</a></div><!--caption a7--><div class="caption"><p id="__p32">Kaplan-Meier curves. Progression-free survival (PFS) curves for (A) rs438034 (<em>CENPF</em> R2943G), (B) rs2064501 (<em>IL22RA2</em>), (C) rs2255235, (D) rs11158493 (<em>PPP2R5E</em>), (E) rs1949733, (F) rs10903420 (<em>ADARB2</em>), (G) rs1342899 and (H) rs6457160. (A) Progression-free survival curves associated with carriers of the C allele are shown as a solid line. The dashed line depicts the survival curve for those with the at risk variant genotype. (B) Progression-free survival curves associated with carriers of the T allele are shown as a solid line. The dashed line depicts the survival curve for those with the at risk variant genotype. (C) Progression-free survival curves associated with G homozygosity are shown as a solid line. The dashed and broken lines depict the survival curves for heterozygosity and A homozygosity respectively. (D) Lines are as defined in (B). (E) Progression-free survival curves associated with G homozygosity are shown as a solid line. The dashed and broken lines depict the survival curves for heterozygosity and A homozygosity, respectively. (F) Progression-free survival curves associated with carriers of the A allele are shown as a solid line. The dashed line depicts the survival curve for those with the at risk variant genotype. (G) Lines are as defined in (E). (H) Progression-free survival curves associated with carriers of the G allele are shown as a solid line. The dashed line depicts the survival curve for those with at risk variant genotype.</p></div></div></div><p id="__p25">rs2064501 maps to intron 4 of the gene encoding inter-leukin 22 receptor, alpha-2 (<em>IL22RA2</em>, MIM 606648). <em>IL22RA2</em> participates in the production of acute-phase reactants via interleukin-22, secreted by T cells. Under a dominant model, carrier status for the T allele of rs2064501 was associated with a more favorable prognosis (HR=0.56; 95% CI: 0.43–0.72; <em>P</em>=1.00×10<sup>−5</sup>). The 5-year progression-free survival rate for carriers of the T minor allele was 21.1% (95% CI: 16.6–26.8%) compared to 7.7% (95% CI: 3.7–15.7%) for non-carriers (<a href="/pmc/articles/PMC3186311/figure/f2-0961496/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-0961496" rid-ob="ob-f2-0961496" co-legend-rid="lgnd_f2-0961496"><span>Figure 2B</span></a>).</p><p id="__p26">Circulating levels of β<sub>2</sub> microglobulin (<em>B2M</em>, MIM 109700) have been reported to influence patients’ outcome in CLL.<sup><a href="#b18-0961496" rid="b18-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_545222791" role="button" aria-expanded="false" aria-haspopup="true">18</a></sup> This is supported by an analysis of the data from the CLL-4 trial in which high levels of β<sub>2</sub> microglobulin (defined as ≥4 mg/L) were significantly associated with poorer progression-free survival (<em>P</em>=0.0001).<sup><a href="#b19-0961496" rid="b19-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857533" role="button" aria-expanded="false" aria-haspopup="true">19</a></sup> rs2255235 mapping 5′ to <em>B2M</em> provided evidence of an association between genetic variation at this locus and progression-free survival (<em>P</em>=3.10×10<sup>−5</sup>). The hazard ratios for heterozygosity and TT homozygosity were 1.63 (95% CI: 1.23–2.16) and 3.07 (95% CI: 1.41–6.67), respectively (<em>P</em>=3.10×10<sup>−5</sup>). The 5-year progression-free survival associated with GG homozygosity was 18.7% (95% CI: 14.6–23.9%) compared to 13.2% (95% CI: 7.2–24.3%) for GT heterozygosity and 14.3% (95% CI: 2.3–87.7%) for TT homozygosity (<a href="/pmc/articles/PMC3186311/figure/f2-0961496/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-0961496" rid-ob="ob-f2-0961496" co-legend-rid="lgnd_f2-0961496"><span>Figure 2C</span></a>). While a relationship between TT genotype and poor progression-free survival was shown, particularly striking in the early years, this observation was based on only seven patients. To investigate whether the rs2255235 genotype influenced β<sub>2</sub> microglobulin level we made use of data from 239 of the 356 genotyped individuals for whom β<sub>2</sub> microglobulin had been previously measured.<sup><a href="#b19-0961496" rid="b19-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857525" role="button" aria-expanded="false" aria-haspopup="true">19</a></sup> There was no difference in the β<sub>2</sub> microglobulin levels measured, or the quantity of missing β<sub>2</sub> microglobulin data between the genotyped and non-genotyped patients, and a relationship between β<sub>2</sub> microglobulin and progression-free survival was apparent in all groups. However, no statistically significant association between genotype and β<sub>2</sub> microglobulin level was observed (<em>P</em>=0.6).</p><p id="__p27">An association was shown for three highly correlated SNP (r<sup>2</sup>&gt;0.7; rs3783741, rs1012145, rs11158493) mapping to protein phosphatase 2A, regulatory subunit B (B56), epsilon isoform (<em>PPP2R5E</em>, MIM 601647), the strongest evidence being provided by rs11158493 (<em>P</em>=8.50×10<sup>−7</sup>) which maps to intron 2 of <em>PPP2R5E</em>; moreover under a dominant model the association was statistically significant at the genome-wide threshold (<em>P</em>=7.12×10<sup>−8</sup>), with carrier status for the T minor allele conferring a more favorable progression-free survival (HR=0.50; 95% CI: 0.39–0.64). The 5-year progression-free survival rate for carriers of the T allele was 28.1% (95% CI: 21.1–37.4%) compared to 12.3% (95% CI: 8.7–17.3%) for non-carriers (<a href="/pmc/articles/PMC3186311/figure/f2-0961496/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-0961496" rid-ob="ob-f2-0961496" co-legend-rid="lgnd_f2-0961496"><span>Figure 2D</span></a>). <em>PPP2R5E</em> has been implicated in a variety of regulatory processes including cell growth and gene transcription. Expression of <em>PPP2R5E</em> was correlated with rs3783741 and rs1012145 genotype (<em>P</em>=0.015) with increased expression being associated with risk genotype (<a href="/pmc/articles/PMC3186311/figure/f3-0961496/" target="figure" class="fig-table-link figpopup" rid-figpopup="f3-0961496" rid-ob="ob-f3-0961496" co-legend-rid="lgnd_f3-0961496"><span>Figure 3</span></a>; <em>Online Supplementary Table S2</em>). Paradoxically, expression of <em>PPP2R5C</em> has been reported to be down-regulated in progressive CLL.<sup><a href="#b20-0961496" rid="b20-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857532" role="button" aria-expanded="false" aria-haspopup="true">20</a></sup></p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="f3-0961496" co-legend-rid="lgnd_f3-0961496"><a href="/pmc/articles/PMC3186311/figure/f3-0961496/" target="figure" rid-figpopup="f3-0961496" rid-ob="ob-f3-0961496"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140613479163712" class="figure"><a href="/pmc/articles/PMC3186311/figure/f3-0961496/" target="figure" rid-figpopup="f3-0961496" rid-ob="ob-f3-0961496"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=3186311_961496.fig3.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is 961496.fig3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC3186311/bin/961496.fig3.jpg"></a></div><div id="largeobj_idm140613479163712" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC3186311/figure/f3-0961496/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_f3-0961496"><div><a class="figpopup" href="/pmc/articles/PMC3186311/figure/f3-0961496/" target="figure" rid-figpopup="f3-0961496" rid-ob="ob-f3-0961496">Figure 3.</a></div><!--caption a7--><div class="caption"><p id="__p36">Relationship between lymphocyte mRNA expression levels of <em>PPP2R5E</em> and rs1012145 genotype.</p></div></div></div><p id="__p28">Five correlated SNP mapping to 4p16.1 showed an association with progression-free survival (rs747580, rs2631731, rs940136, rs2631753, rs1949733), the strongest association being shown for rs1949733 (<em>P</em>=8.22×10<sup>−7</sup>). Hazard ratios for heterozygosity and AA homozygosity were 1.54 (95% CI: 1.21–1.97), and 2.36 (95% CI: 1.60–3.47), respectively; corresponding 5-year progression-free survival rates were 24.4% (95% CI: 18.9–31.5%), 11.9% (95% CI: 7.5–18.8%) and 3.1% (95% CI: 0.5–21.5%), respectively (<a href="/pmc/articles/PMC3186311/figure/f2-0961496/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-0961496" rid-ob="ob-f2-0961496" co-legend-rid="lgnd_f2-0961496"><span>Figure 2E</span></a>). rs1949733 maps centromeric to a number of genes including acyl-coenzyme A oxidase 3, pristanoyl isoform b (<em>ACOX3</em>, MIM 603402) and predicted transcripts (e.g. C4orf23) which may be the basis for the observed association. This assertion is supported by the strong relationship found between rs747580 genotype and <em>ACOX3</em> expression in Epstein-Barr virus-transformed lymphocytes (<em>P</em>=1.08×10<sup>−6</sup>; <em>Online Supplementary Table S2</em>).</p><p id="__p29">Adenosine deaminase, RNA-specific, b2 (<em>ADARB2</em>, MIM 602065) RNA-editing deaminase-2 (<em>RED2</em>, or <em>ADARB2</em>) is a member of the double-stranded RNA adenosine deaminases which play a role in RNA-editing, a process which has been implicated as an additional epigenetic mechanism relevant to cancer development and progression.<sup><a href="#b21-0961496" rid="b21-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857528" role="button" aria-expanded="false" aria-haspopup="true">21</a></sup> Two SNP, rs10903420 and rs1007147, which are in perfect LD and map to intron 3 of <em>ADARB2</em> provided evidence of an association (<em>P</em>=3.00×10<sup>−5</sup>; HR=0.58, 95% CI: 0.46–0.75). The 5-year progression-free survival associated with rs10903420 was 21.8% (95% CI: 17.3–27.4%) for carriers of the A minor allele, compared with 5.2% (95% CI: 2.0–13.5%) for non-carriers (<a href="/pmc/articles/PMC3186311/figure/f2-0961496/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-0961496" rid-ob="ob-f2-0961496" co-legend-rid="lgnd_f2-0961496"><span>Figure 2F</span></a>).</p><p id="__p30">Strong evidence for an association between progression-free survival and variation at 9q31.1 was provided by rs1342899 (<em>P</em>=7.72×10<sup>−7</sup>). Hazard ratios associated with heterozygosity and homozygosity for the A minor allele were 0.68 (95% CI: 0.54–0.86) and 0.32 (95% CI: 0.19–0.54) respectively, with 5-year progression-free survival rates of 12.4% (95% CI: 8.3–18.3%) for GG homozygotes, 19.8% (95% CI: 14.3–27.3) for heterozygotes and 40.7% (95% CI: 25.9–64.2%) for AA homozygotes (<a href="/pmc/articles/PMC3186311/figure/f2-0961496/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-0961496" rid-ob="ob-f2-0961496" co-legend-rid="lgnd_f2-0961496"><span>Figure 2G</span></a>).</p><p id="__p33">Evidence for the role of genetic variation in the gene neural precursor cell expressed developmentally downregulated 9 (<em>NEDD9</em>, MIM 602265) was provided by rs6457160 (<em>P</em>=8.60×10<sup>−5</sup>). <em>NEDD9</em> is an important component of a cytoskeleton-linked signaling pathway initiated by integrins regulating FAK and cell spreading, and has been shown to play a role in response to extracellular cues that drive invasion and metastasis.<sup><a href="#b22-0961496" rid="b22-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857545" role="button" aria-expanded="false" aria-haspopup="true">22</a></sup> Homozygosity for the A minor allele was associated with poorer progression-free survival (HR=1.72; 95%CI: 1.31–2.26) and a 5-year progression-free survival of 7.3% (95% CI: 3.3%–16.4%) compared to 20.5% (95% CI: 16.2%–25.9%) for heterozygotes and G homozygotes (<a href="/pmc/articles/PMC3186311/figure/f2-0961496/" target="figure" class="fig-table-link figpopup" rid-figpopup="f2-0961496" rid-ob="ob-f2-0961496" co-legend-rid="lgnd_f2-0961496"><span>Figure 2H</span></a>).</p><p id="__p34" class="p p-last">We have previously shown that polymorphic variation at 2q13 (rs17483466), 2q37.1 (rs13397985, <em>SP140</em>), 6p25.3 (rs872071, <em>IRF4</em>), 11q24.1 (rs735665), 15q23 (rs7176508) and 19q13.32 (rs11083846, <em>PRKD2</em>) influences the risk of CLL.<sup><a href="#b7-0961496" rid="b7-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857530" role="button" aria-expanded="false" aria-haspopup="true">7</a></sup> Associations with progression-free survival (<em>P</em>=0.85, 0.74, 0.98, 0.94, 0.55 and 0.37, respectively) provided no evidence that these variants influence survival of patients with CLL.</p></div><div id="__sec17" class="sec"><h3 id="__sec17title">Relationship between single nucleotide polymorphisms and chemotherapy</h3><p id="__p35" class="p p-first">We examined for potential interactive effects between various SNP and response to chemotherapy on progression-free survival. Four of the 52 SNP showed evidence for an interaction at the 0.05 threshold: rs3103078 mapping to 4p16.1, rs6457160 mapping to <em>NEDD9</em>, rs215702 mapping to 7p14.3, and rs2061450 mapping to 18q21.33. <em>Online Supplementary Table S3</em> details the relationship between interactions for these four variants. For both rs6457160 and rs215702, the impact of genotype was greater in patients treated with fludarabine (HR=2.02, 95% CI: 1.44–2.84 and HR=1.79, 95% CI: 1.31–2.44, respectively) than in those treated with chlorambucil (HR=1.37, 95% CI: 1.09–1.71 and HR=1.53, 95% CI: 1.20–1.95, respectively) or fludarabine and cyclophosphamide (HR=0.96, 95% CI: 0.66–1.40 and HR=1.01, 95% CI: 0.71–1.44, respectively). For rs2061450 the impact of genotype was greater in patients treated with the alkylating agent chlorambucil (HR=1.84, 95% CI: 1.42–2.38) than in those treated with purine analogs (HR for fludarabine=1.45, 95% CI: 1.02–2.08; HR for fludarabine + cyclophosphamide=0.98, 95% CI: 0.64–1.50). For rs3103078 the impact of genotype was greater in patients treated with the combination of fludarabine and cyclophosphamide (HR=1.90, 95% CI: 1.35–2.67), than in those treated with chlorambucil (HR=1.40, 95% CI: 1.13–1.73) or fludarabine monotherapy (HR=0.97, 95% CI: 0.70–1.33).</p></div><div id="__sec18" class="sec sec-last"><h3 id="__sec18title">Replication results</h3><p id="__p37" class="p p-first-last">We looked further at ten noteworthy SNP selected on the basis of <em>P</em> values and robustness of associations after adjustment for <em>IGHV</em> status (rs438034, rs9883654, rs1949733, rs10504154, rs10990381, rs1342899, rs1168987, rs11158493, rs2255235 and rs2228671), using an independent series of 380 CLL Italian patients, seeking to replicate findings. After a median follow-up of 67 months, 172 of the patients had required treatment and 90 had died. Statistical analysis of the relationship between SNP genotype and progression-free survival was made by multivariate analysis adjusting for age, sex, Binet stage, <em>IGHV</em> status, CD38 and <em>TP53</em> mutation. While for some SNP there was evidence for an association with progression-free survival consistent with that seen in the clinical trial, none of the associations was statistically significant (<em>i.e. P</em>&gt;0.05; <em>Online Supplementary Table S4</em>).</p></div></div><div id="__sec19" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec19title">Discussion</h2><p id="__p38" class="p p-first">Genome-wide SNP genotype data generated from 356 patients within the CLL-4 trial have allowed us to gain insight into determinants influencing the biology of CLL and identify a number of genetic variants associated with progression-free survival. Notably a number of the SNP map to genes previously implicated as prognostic markers for malignancy, <em>CENPF</em>, and genes with a proven role in B-cell biology, <em>B2M</em> and <em>IL22RA2</em>, or with metastatic potential, <em>NEDD9</em>.</p><p id="__p39">A major strength of our study is that it was based on a large series of patients entered into a phase III randomized trial thus minimizing biases. In addition, our analysis is unlikely to have been confounded by population stratification as we excluded non-Western European ancestral cases from the analysis. Furthermore we were able to adjust for the major molecular covariate, <em>IGHV</em> mutation status, and identify SNP independently predictive of progression-free survival.</p><p id="__p40">It is intriguing that a number of the association signals map to genes with biological plausibility as determinants of prognosis. Furthermore, <em>CENPF</em> 2943T carrier status has previously been shown to be associated with a poorer prognosis in patients with breast cancer suggesting a generic effect on tumor prognosis.<sup><a href="#b17-0961496" rid="b17-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857535" role="button" aria-expanded="false" aria-haspopup="true">17</a></sup> As the SNP maps to exon 18 of the gene and the C&gt;T change leads to substitution of glycine for arginine, the SNP may be directly functional. This does not, however, exclude the possibility that the association may be a consequence of LD with a causal variant, as the sequence change is predicted to be tolerated. Indeed excluding <em>CENPF</em> R2943G (rs438034), <em>SLC30A8</em> R325W (rs13266634), and <em>ZFP64</em> S451N (rs3746414), the majority of the SNP genotyped are generally not themselves candidates for causality. Accepting the caveat that HapMap is not comprehensive, we interrogated HapMap to identify non-synonymous SNP highly correlated (r<sup>2</sup>&gt;0.8) with the most strongly associated SNP. In this analysis we did not identify any correlated non-synonymous SNP within associated genes. A failure to demonstrate association suggests that many of the associations identified so far are mediated through LD with sequence changes that influence gene expression rather than protein sequences or through LD with low frequency variants (i.e. variants with minor allele frequencies of 0.01–0.05) that are not catalogued by HapMap. Such an assertion is supported by data showing an association between genotype and mRNA expression of the respective transcript in Epstein-Barr virus-lymphoblastoid cell lines.</p><p id="__p41">Our study also provides insight into the genetic architecture of variants likely to influence patients’ prognosis; specifically, our findings suggest that there are unlikely to be many common loci conferring hazard ratios of greater than 1.5 as the power of our analysis to detect this class of variant was high. Hence, if patients’ prognosis is significantly influenced by genotype, by implication it is probable that a large number of variants influence the patients’ outcome.</p><p id="__p42">Although our study demonstrates strong associations between a number of SNP and progression-free survival, with biological plausibility, there are limitations to our findings. A major one is that replication analysis did not attain statistically significant levels. This failure of replication is not necessarily unexpected, given differences between the two case series. As previously discussed, replication studies face the risk of non-validation because of the lack of generalizability,<sup><a href="#b23-0961496" rid="b23-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857527" role="button" aria-expanded="false" aria-haspopup="true">23</a></sup><sup>,</sup><sup><a href="#b24-0961496" rid="b24-0961496" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_233857537" role="button" aria-expanded="false" aria-haspopup="true">24</a></sup> especially when there can be significant differences in individual patients’ management. Our discovery cases were UK patients participating in a large phase III clinical trial: each patient had, therefore, received standardized management and treatment. In contrast, the cases in the replication phase were patients undergoing routine clinical care and thus likely to have had differing treatment and management over the period of ascertainment. This is reflected in the characteristics of the two groups of patients, who showed significant differences in survival time.</p><p id="__p43">Furthermore, there is the issue of genetic heterogeneity between the two sets of patients which can erode the probability of demonstrating replication. Since most SNP associations are unlikely to be directly causal, replication of associations is contingent on patterns of LD being consistent between populations. Differences in LD structure between northern and southern European populations are well documented. Evidence for this and thus a possible reason for failure to replicate findings is given by the fact that allele frequencies for two of the ten SNP (<em>P</em>&lt;0.05) were significantly different between the two sets of patients studied.</p><p id="__p44" class="p p-last">In conclusion, accepting the above caveats we have provided evidence implicating variations in a number of genes as a possible determinant of the outcome of patients with CLL. While any germline variant is unlikely to replace staging schemes and conventional molecular markers, they do have potential to assist in distinguishing different outcome patterns among patients with the same stage of disease, opening up the possibility of a rational, targeted approach to treatment based on a combination of the patients’ genotype and tumor characteristics.</p></div><div id="idm140613474954272" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140613474954272title">Acknowledgments</h2><div class="sec"><p id="__p45">The authors would like to thank all patients and clinicians who participated in the LRF CLL-4 trial.</p></div></div><div id="idm140613474953280" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140613474953280title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140613474953152"></p><p id="__p46" class="p p-first-last">Funding: this work was primarily supported by a grant from Leukaemia Research and the MRC (G8223452). Additional funding was provided by the Arbib Foundation and Cancer Research UK.</p><p></p><p class="fn sec" id="idm140613471340224"></p><p id="__p47" class="p p-first-last">The online version of this article has a Supplementary Appendix.</p><p></p><p class="fn sec" id="idm140613471339520"></p><p id="__p48" class="p p-first"><strong>Authorship and Disclosures</strong></p><p id="__p49" class="p p-last">The information provided by the authors about contributions from persons listed as authors and in acknowledgments is available with the full text of this paper at <a href="http://www.haematologica.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.haematologica.org</a>.</p><p></p><p class="fn sec" id="idm140613478395408"></p><p id="__p50" class="p p-first-last">Financial and other disclosures provided by the authors using the ICMJE (<a href="http://www.icmje.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.icmje.org</a>) Uniform Format for Disclosure of Competing Interests are also available at <a href="http://www.haematologica.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.haematologica.org</a>.</p><p></p></div></div><div id="idm140613477958400" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm140613477958400title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="b1-0961496">1. <span class="element-citation">Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. <span><span class="ref-journal">Blood. </span>2004;<span class="ref-vol">103</span>(12):4389–95.</span> [<a href="/pubmed/14962897" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Chronic+lymphocytic+leukemia:+revelations+from+the+B-cell+receptor&amp;author=FK+Stevenson&amp;author=F+Caligaris-Cappio&amp;volume=103&amp;issue=12&amp;publication_year=2004&amp;pages=4389-95&amp;pmid=14962897&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b2-0961496">2. <span class="element-citation">Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, et al.  Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph) <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">110</span>(2):695–708.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1924473/">PMC free article</a>]</span> [<a href="/pubmed/17389762" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Proposed+classification+of+lymphoid+neoplasms+for+epidemiologic+research+from+the+Pathology+Working+Group+of+the+International+Lymphoma+Epidemiology+Consortium+(InterLymph)&amp;author=LM+Morton&amp;author=JJ+Turner&amp;author=JR+Cerhan&amp;author=MS+Linet&amp;author=PA+Treseler&amp;volume=110&amp;issue=2&amp;publication_year=2007&amp;pages=695-708&amp;pmid=17389762&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b3-0961496">3. <span class="element-citation">Binet JL. Prognostic factors in chronic lymphocytic leukaemia. <span><span class="ref-journal">Haematologica. </span>1999;<span class="ref-vol">84</span>(Suppl EHA-4):96–7.</span> [<a href="/pubmed/10907482" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Haematologica&amp;title=Prognostic+factors+in+chronic+lymphocytic+leukaemia&amp;author=JL+Binet&amp;volume=84&amp;issue=Suppl+EHA-4&amp;publication_year=1999&amp;pages=96-7&amp;pmid=10907482&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b4-0961496">4. <span class="element-citation">Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al.  Genomic aberrations and survival in chronic lymphocytic leukemia. <span><span class="ref-journal">N Engl J Med. </span>2000;<span class="ref-vol">343</span>(26):1910–6.</span> [<a href="/pubmed/11136261" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Genomic+aberrations+and+survival+in+chronic+lymphocytic+leukemia&amp;author=H+Dohner&amp;author=S+Stilgenbauer&amp;author=A+Benner&amp;author=E+Leupolt&amp;author=A+Krober&amp;volume=343&amp;issue=26&amp;publication_year=2000&amp;pages=1910-6&amp;pmid=11136261&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b5-0961496">5. <span class="element-citation">Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. <span><span class="ref-journal">Blood. </span>1999;<span class="ref-vol">94</span>(6):1848–54.</span> [<a href="/pubmed/10477713" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Unmutated+Ig+V(H)+genes+are+associated+with+a+more+aggressive+form+of+chronic+lymphocytic+leukemia&amp;author=TJ+Hamblin&amp;author=Z+Davis&amp;author=A+Gardiner&amp;author=DG+Oscier&amp;author=FK+Stevenson&amp;volume=94&amp;issue=6&amp;publication_year=1999&amp;pages=1848-54&amp;pmid=10477713&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b6-0961496">6. <span class="element-citation">Del Poeta G, Maurillo L, Venditti A, Buccisano F, Epiceno AM, Capelli G, et al.  Clinical significance of CD38 expression in chronic lymphocytic leukemia. <span><span class="ref-journal">Blood. </span>2001;<span class="ref-vol">98</span>(9):2633–9.</span> [<a href="/pubmed/11675331" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Clinical+significance+of+CD38+expression+in+chronic+lymphocytic+leukemia&amp;author=G+Del+Poeta&amp;author=L+Maurillo&amp;author=A+Venditti&amp;author=F+Buccisano&amp;author=AM+Epiceno&amp;volume=98&amp;issue=9&amp;publication_year=2001&amp;pages=2633-9&amp;pmid=11675331&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b7-0961496">7. <span class="element-citation">Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R, et al.  A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. <span><span class="ref-journal">Nat Genet. </span>2008;<span class="ref-vol">40</span>(10):1204–10.</span> [<a href="/pubmed/18758461" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=A+genome-wide+association+study+identifies+six+susceptibility+loci+for+chronic+lymphocytic+leukemia&amp;author=MC+Di+Bernardo&amp;author=D+Crowther-Swanepoel&amp;author=P+Broderick&amp;author=E+Webb&amp;author=G+Sellick&amp;volume=40&amp;issue=10&amp;publication_year=2008&amp;pages=1204-10&amp;pmid=18758461&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b8-0961496">8. <span class="element-citation">Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, Mansouri M, et al.  Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>(2):132–6.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5321238/">PMC free article</a>]</span> [<a href="/pubmed/20062064" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Common+variants+at+2q37.3,+8q24.21,+15q21.3+and+16q24.1+influence+chronic+lymphocytic+leukemia+risk&amp;author=D+Crowther-Swanepoel&amp;author=P+Broderick&amp;author=MC+Di+Bernardo&amp;author=SE+Dobbins&amp;author=M+Torres&amp;volume=42&amp;issue=2&amp;publication_year=2010&amp;pages=132-6&amp;pmid=20062064&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b9-0961496">9. <span class="element-citation">Catovsky D, Richards S, Matutes E, Oscier D, Dyer MJ, Bezares RF, et al.  Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial. <span><span class="ref-journal">Lancet. </span>2007;<span class="ref-vol">370</span>(9583):230–9.</span> [<a href="/pubmed/17658394" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Assessment+of+fludarabine+plus+cyclophosphamide+for+patients+with+chronic+lymphocytic+leukaemia+(the+LRF+CLL4+Trial):+a+randomised+controlled+trial&amp;author=D+Catovsky&amp;author=S+Richards&amp;author=E+Matutes&amp;author=D+Oscier&amp;author=MJ+Dyer&amp;volume=370&amp;issue=9583&amp;publication_year=2007&amp;pages=230-9&amp;pmid=17658394&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b10-0961496">10. <span class="element-citation">Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. <span><span class="ref-journal">Nucleic Acids Res. </span>2002;<span class="ref-vol">30</span>(17):3894–900.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC137415/">PMC free article</a>]</span> [<a href="/pubmed/12202775" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res&amp;title=Human+non-synonymous+SNPs:+server+and+survey&amp;author=V+Ramensky&amp;author=P+Bork&amp;author=S+Sunyaev&amp;volume=30&amp;issue=17&amp;publication_year=2002&amp;pages=3894-900&amp;pmid=12202775&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b11-0961496">11. <span class="element-citation">Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. <span><span class="ref-journal">Genome Res. </span>2001;<span class="ref-vol">11</span>(5):863–74.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC311071/">PMC free article</a>]</span> [<a href="/pubmed/11337480" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Res&amp;title=Predicting+deleterious+amino+acid+substitutions&amp;author=PC+Ng&amp;author=S+Henikoff&amp;volume=11&amp;issue=5&amp;publication_year=2001&amp;pages=863-74&amp;pmid=11337480&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b12-0961496">12. <span class="element-citation">Xi T, Jones IM, Mohrenweiser HW. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. <span><span class="ref-journal">Genomics. </span>2004;<span class="ref-vol">83</span>(6):970–9.</span> [<a href="/pubmed/15177551" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genomics&amp;title=Many+amino+acid+substitution+variants+identified+in+DNA+repair+genes+during+human+population+screenings+are+predicted+to+impact+protein+function&amp;author=T+Xi&amp;author=IM+Jones&amp;author=HW+Mohrenweiser&amp;volume=83&amp;issue=6&amp;publication_year=2004&amp;pages=970-9&amp;pmid=15177551&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b13-0961496">13. <span class="element-citation">Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R, et al.  Genome-wide associations of gene expression variation in humans. <span><span class="ref-journal">PLoS Genet. </span>2005;<span class="ref-vol">1</span>(6):e78.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1315281/">PMC free article</a>]</span> [<a href="/pubmed/16362079" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Genome-wide+associations+of+gene+expression+variation+in+humans&amp;author=BE+Stranger&amp;author=MS+Forrest&amp;author=AG+Clark&amp;author=MJ+Minichiello&amp;author=S+Deutsch&amp;volume=1&amp;issue=6&amp;publication_year=2005&amp;pages=e78&amp;pmid=16362079&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b14-0961496">14. <span class="element-citation">Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, et al.  Relative impact of nucleotide and copy number variation on gene expression phenotypes. <span><span class="ref-journal">Science. </span>2007;<span class="ref-vol">315</span>(5813):848–53.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2665772/">PMC free article</a>]</span> [<a href="/pubmed/17289997" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Relative+impact+of+nucleotide+and+copy+number+variation+on+gene+expression+phenotypes&amp;author=BE+Stranger&amp;author=MS+Forrest&amp;author=M+Dunning&amp;author=CE+Ingle&amp;author=C+Beazley&amp;volume=315&amp;issue=5813&amp;publication_year=2007&amp;pages=848-53&amp;pmid=17289997&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b15-0961496">15. <span class="element-citation">Cuzick J. A Wilcoxon-type test for trend. <span><span class="ref-journal">Stat Med. </span>1985;<span class="ref-vol">4</span>(1):87–90.</span> [<a href="/pubmed/3992076" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Stat+Med&amp;title=A+Wilcoxon-type+test+for+trend&amp;author=J+Cuzick&amp;volume=4&amp;issue=1&amp;publication_year=1985&amp;pages=87-90&amp;pmid=3992076&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b16-0961496">16. <span class="element-citation">Clayton DG, Walker NM, Smyth DJ, Pask R, Cooper JD, Maier LM, et al.  Population structure, differential bias and genomic control in a large-scale, case-control association study. <span><span class="ref-journal">Nat Genet. </span>2005;<span class="ref-vol">37</span>(11):1243–6.</span> [<a href="/pubmed/16228001" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Population+structure,+differential+bias+and+genomic+control+in+a+large-scale,+case-control+association+study&amp;author=DG+Clayton&amp;author=NM+Walker&amp;author=DJ+Smyth&amp;author=R+Pask&amp;author=JD+Cooper&amp;volume=37&amp;issue=11&amp;publication_year=2005&amp;pages=1243-6&amp;pmid=16228001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b17-0961496">17. <span class="element-citation">Brendle A, Brandt A, Johansson R, Enquist K, Hallmans G, Hemminki K, et al.  Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study. <span><span class="ref-journal">Eur J Cancer. </span>2009;<span class="ref-vol">45</span>(3):435–42.</span> [<a href="/pubmed/19008095" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Cancer&amp;title=Single+nucleotide+polymorphisms+in+chromosomal+instability+genes+and+risk+and+clinical+outcome+of+breast+cancer:+a+Swedish+prospective+case-control+study&amp;author=A+Brendle&amp;author=A+Brandt&amp;author=R+Johansson&amp;author=K+Enquist&amp;author=G+Hallmans&amp;volume=45&amp;issue=3&amp;publication_year=2009&amp;pages=435-42&amp;pmid=19008095&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b18-0961496">18. <span class="element-citation">Wierda WG, O’Brien S, Wang X, Faderl S, Ferrajoli A, Do KA, et al.  Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment. <span><span class="ref-journal">J Clin Oncol. </span>2009;<span class="ref-vol">27</span>(10):1637–43.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4890649/">PMC free article</a>]</span> [<a href="/pubmed/19224852" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Oncol&amp;title=Characteristics+associated+with+important+clinical+end+points+in+patients+with+chronic+lymphocytic+leukemia+at+initial+treatment&amp;author=WG+Wierda&amp;author=S+O’Brien&amp;author=X+Wang&amp;author=S+Faderl&amp;author=A+Ferrajoli&amp;volume=27&amp;issue=10&amp;publication_year=2009&amp;pages=1637-43&amp;pmid=19224852&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b19-0961496">19. <span class="element-citation">Oscier D, Wade R, Davis Z, Morilla A, Best G, Richards S, et al.  Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation. <span><span class="ref-journal">Haematologica. </span>2010;<span class="ref-vol">95</span>(10):1705–12.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2948096/">PMC free article</a>]</span> [<a href="/pubmed/20511662" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Haematologica&amp;title=Prognostic+factors+identified+three+risk+groups+in+the+LRF+CLL4+trial,+independent+of+treatment+allocation&amp;author=D+Oscier&amp;author=R+Wade&amp;author=Z+Davis&amp;author=A+Morilla&amp;author=G+Best&amp;volume=95&amp;issue=10&amp;publication_year=2010&amp;pages=1705-12&amp;pmid=20511662&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b20-0961496">20. <span class="element-citation">Falt S, Merup M, Gahrton G, Lambert B, Wennborg A. Identification of progression markers in B-CLL by gene expression profiling. <span><span class="ref-journal">Exp Hematol. </span>2005;<span class="ref-vol">33</span>(8):883–93.</span> [<a href="/pubmed/16038780" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Hematol&amp;title=Identification+of+progression+markers+in+B-CLL+by+gene+expression+profiling&amp;author=S+Falt&amp;author=M+Merup&amp;author=G+Gahrton&amp;author=B+Lambert&amp;author=A+Wennborg&amp;volume=33&amp;issue=8&amp;publication_year=2005&amp;pages=883-93&amp;pmid=16038780&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b21-0961496">21. <span class="element-citation">Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, et al.  Altered adenosine-to-inosine RNA editing in human cancer. <span><span class="ref-journal">Genome Res. </span>2007;<span class="ref-vol">17</span>(11):1586–95.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2045141/">PMC free article</a>]</span> [<a href="/pubmed/17908822" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genome+Res&amp;title=Altered+adenosine-to-inosine+RNA+editing+in+human+cancer&amp;author=N+Paz&amp;author=EY+Levanon&amp;author=N+Amariglio&amp;author=AB+Heimberger&amp;author=Z+Ram&amp;volume=17&amp;issue=11&amp;publication_year=2007&amp;pages=1586-95&amp;pmid=17908822&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b22-0961496">22. <span class="element-citation">Singh MK, Dadke D, Nicolas E, Serebriiskii IG, Apostolou S, Canutescu A, et al.  A novel Cas family member, HEPL, regulates FAK and cell spreading. <span><span class="ref-journal">Mol Biol Cell. </span>2008;<span class="ref-vol">19</span>(4):1627–36.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2291417/">PMC free article</a>]</span> [<a href="/pubmed/18256281" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Biol+Cell&amp;title=A+novel+Cas+family+member,+HEPL,+regulates+FAK+and+cell+spreading&amp;author=MK+Singh&amp;author=D+Dadke&amp;author=E+Nicolas&amp;author=IG+Serebriiskii&amp;author=S+Apostolou&amp;volume=19&amp;issue=4&amp;publication_year=2008&amp;pages=1627-36&amp;pmid=18256281&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b23-0961496">23. <span class="element-citation">Gorroochurn P, Hodge SE, Heiman GA, Durner M, Greenberg DA. Non-replication of association studies: “pseudo-failures” to replicate? <span><span class="ref-journal">Genet Med. </span>2007;<span class="ref-vol">9</span>(6):325–31.</span> [<a href="/pubmed/17575498" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genet+Med&amp;title=Non-replication+of+association+studies:+“pseudo-failures”+to+replicate?&amp;author=P+Gorroochurn&amp;author=SE+Hodge&amp;author=GA+Heiman&amp;author=M+Durner&amp;author=DA+Greenberg&amp;volume=9&amp;issue=6&amp;publication_year=2007&amp;pages=325-31&amp;pmid=17575498&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="b24-0961496">24. <span class="element-citation">Morgan TM, Krumholz HM, Lifton RP, Spertus JA. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. <span><span class="ref-journal">JAMA. </span>2007;<span class="ref-vol">297</span>(14):1551–61.</span> [<a href="/pubmed/17426274" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Nonvalidation+of+reported+genetic+risk+factors+for+acute+coronary+syndrome+in+a+large-scale+replication+study&amp;author=TM+Morgan&amp;author=HM+Krumholz&amp;author=RP+Lifton&amp;author=JA+Spertus&amp;volume=297&amp;issue=14&amp;publication_year=2007&amp;pages=1551-61&amp;pmid=17426274&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></div></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#idm140613482423696title">Abstract</a></li><li><a href="#__sec5title">Introduction</a></li><li><a href="#__sec6title">Design and Methods</a></li><li><a href="#__sec13title">Results</a></li><li><a href="#__sec19title">Discussion</a></li><li><a href="#idm140613474954272title">Acknowledgments</a></li><li><a href="#idm140613474953280title">Footnotes</a></li><li><a href="#idm140613477958400title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Haematologica</span> are provided here courtesy of <strong>Ferrata Storti Foundation</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3186311/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3186311/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3186311/pdf/0961496.pdf">PDF (720K)</a></li> | <li><a href="#" data-citationid="PMC3186311" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3186311%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3186311%2F&amp;text=Association%20between%20single%20nucleotide%20polymorphism-genotype%20and%20outcome%20of%20patients%20with%20chronic%20lymphocytic%20leukemia%20in%20a%20randomized%20chemotherapy%20trial" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3186311%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="21659360" data-aiid="3186311" data-aid="3186311" data-iid="200717" data-domainid="820" data-domain="haematol" data-accid="PMC3186311" data-md5="e3cbef6c43f439cd2a2790b8dd01a22e">
<div class="portlet pubmed_favoritesad">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Save items</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="pmfavad" toggles="ui-portlet_content-4" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-4" aria-hidden="false"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<input name="absid" id="absid" value="3186311" type="hidden"><div id="pubmed_favoritesad" class="empty" data-db="pmc">
<span role="menubar"><div class="ui-ncbisetswitch ltd-hover" role="menuitem" aria-expanded="false" aria-haspopup="true"><a href="/myncbi/collections/" class="jig-ncbisetswitch blind collink ltd-hover ui-ncbisetswitch-hasStar" id="favList" data-jigconfig="destSelector:'#favUL',starExists:true,createCollectionUrl:'#',manageCollectionsUrl:'/myncbi/collections/'"><span class="star"></span>Add to Favorites</a><a class="ui-ncbisetswitch-button ltd-hover" title="View more options" href="#"><span class="ui-icon ui-icon-triangle-1-s ui-ncbisetswitch-down">View more options</span></a></div></span><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu ui-ncbisetswitch-popper"><ul id="favUL" class="ui-ncbisetswitch-options"></ul><ul class="ui-ncbisetswitch-actions"><li class="ui-ncbisetswitch-actions-create" style="display: block;"><a class="ui-ncbisetswitch-create-collection" href="#">Create collection...</a></li><li class="ui-ncbisetswitch-actions-manage" style="display: block;"><a class="ui-ncbisetswitch-manage-collections" href="/myncbi/collections/">Manage collections...</a></li></ul></div>
</div>
<div class="colloading">loading</div>
<span id="submenu_AddToCollections"><form method="post"><input class="button_apply" name="addtocollection" value="1" type="submit"></form></span>
</div></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" toggles="ui-portlet_content-5" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-5" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/16960146" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Association of a novel regulatory polymorphism (-938C&amp;gt;A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.</a><span class="source">[Blood. 2007]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-6" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nückel H, Frey UH, Bau M, Sellmann L, Stanelle J, Dürig J, Jöckel KH, Dührsen U, Siffert W. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Blood. 2007 Jan 1; 109(1):290-7. Epub 2006 Sep 7.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/18006695" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Scan of 977 nonsynonymous SNPs in CLL4 trial patients for the identification of genetic variants influencing prognosis.</a><span class="source">[Blood. 2008]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-7" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sellick GS, Wade R, Richards S, Oscier DG, Catovsky D, Houlston RS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Blood. 2008 Feb 1; 111(3):1625-33. Epub 2007 Nov 15.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/11114313" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.</a><span class="source">[N Engl J Med. 2000]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-8" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">N Engl J Med. 2000 Dec 14; 343(24):1750-7. </em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/25512118" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">A network meta-analysis of progression free survival and overall survival in first-line treatment of chronic lymphocytic leukemia.</a><span class="source">[Cancer Treat Rev. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-9" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ladyzynski P, Molik M, Foltynski P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Cancer Treat Rev. 2015 Feb; 41(2):77-93. Epub 2014 Dec 4.</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pubmed/17143256" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Chronic lymphocytic leukemia: current and emerging treatment approaches.</a><span class="source">[Clin Adv Hematol Oncol. 2006]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-10" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kay NE, Rai KR, O'Brien S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Adv Hematol Oncol. 2006 Nov; 4(11 Suppl 22):1-10; quiz 11-2. </em>
</div>
</li>
</ul>
<a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=21659360&amp;log%24=relatedreviews&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Reviews&amp;rendering-type=normal">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=21659360&amp;log%24=relatedarticles&amp;logdbfrom=pmc" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|RelatedArticles&amp;TO=Entrez|Pubmed|Related%20Records&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Cited by other articles in PMC</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-11" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-11" aria-hidden="false">
<ul>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6439501/" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Genome‐wide association study of an unusual dolphin mortality event reveals candidate genes for susceptibility and resistance to cetacean morbillivirus</a><span class="source">[Evolutionary Applications. 2018]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-12" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Batley KC, Sandoval‐Castillo J, Kemper CM, Attard CR, Zanardo N, Tomo I, Beheregaray LB, Möller LM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Evolutionary Applications. 2018 Dec 26; 12(4): 718-732</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC6302113/" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Long Interleukin-22 Binding Protein Isoform-1 Is an Intracellular Activator of the Unfolded Protein Response</a><span class="source">[Frontiers in Immunology. 2018]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-13" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gómez-Fernández P, Urtasun A, Paton AW, Paton JC, Borrego F, Dersh D, Argon Y, Alloza I, Vandenbroeck K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Frontiers in Immunology. 2018 Dec 14; 9: 2934</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC4831809/" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment</a><span class="source">[PLoS ONE. 2016]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-14" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Admoni-Elisha L, Nakdimon I, Shteinfer A, Prezma T, Arif T, Arbel N, Melkov A, Zelichov O, Levi I, Shoshan-Barmatz V. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">PLoS ONE. 2016 Apr 14; 11(4): e0148500</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC4589387/" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements</a><span class="source">[PLoS ONE. 2015]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-15" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hayes JE, Trynka G, Vijai J, Offit K, Raychaudhuri S, Klein RJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">PLoS ONE. 2015 Sep 30; 10(9): e0139360</em>
</div>
</li>
<li class="brieflinkpopper two_line">
<a class="brieflinkpopperctrl" href="/pmc/articles/PMC3812212/" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Functional Genetic Polymorphisms in PP2A Subunit Genes Confer Increased Risks of Lung Cancer in Southern and Eastern Chinese</a><span class="source">[PLoS ONE. 2013]</span><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-16" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">
<em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yang R, Yang L, Qiu F, Zhang L, Wang H, Yang X, Deng J, Fang W, Zhou Y, Lu J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">PLoS ONE. 2013 Oct 29; 8(10): e77285</em>
</div>
</li>
</ul>
<a class="seemore" href="citedby/" ref="reftype=relart&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedByInPmc&amp;TO=PMC|Article|CitedBy&amp;rendering-type=normal">See all...</a>
</div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Links</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter ui-ncbitoggler-open" title="Show/hide content" remembercollapsed="true" pgsec_name="PMCVCitedByPmcArticlesP" toggles="ui-portlet_content-17" role="button" aria-expanded="true" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave-open" id="ui-portlet_content-17" aria-hidden="false"><ul>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=pccompound&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pccompound&amp;IdsFromResult=3186311" ref="reftype=Compound&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Compound&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Compound</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-18" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Compound<div class="brieflinkpopdesc">PubChem Compound links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=gene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gene&amp;IdsFromResult=3186311" ref="reftype=Gene&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Gene&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Gene</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-19" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Gene<div class="brieflinkpopdesc">Gene links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=gene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_gene_nucleotide&amp;IdsFromResult=3186311" ref="reftype=Gene%20(nucleotide)&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Gene (nucleotide)</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-20" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Gene (nucleotide)<div class="brieflinkpopdesc">Records in Gene identified from shared sequence links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=geoprofiles&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_geoprofiles&amp;IdsFromResult=3186311" ref="reftype=GEO%20Profiles&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">GEO Profiles</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-21" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">GEO Profiles<div class="brieflinkpopdesc">Related GEO records</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=homologene&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_homologene&amp;IdsFromResult=3186311" ref="reftype=HomoloGene&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|HomoloGene&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">HomoloGene</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-22" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">HomoloGene<div class="brieflinkpopdesc">HomoloGene links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=medgen&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_medgen&amp;IdsFromResult=3186311" ref="reftype=MedGen&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Unknown%20Link%20Name&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">MedGen</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-23" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">MedGen<div class="brieflinkpopdesc">Related information in MedGen</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=nuccore&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_nuccore&amp;IdsFromResult=3186311" ref="reftype=Nucleotide&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Nucleotide&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Nucleotide</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-24" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Nucleotide<div class="brieflinkpopdesc">Published Nucleotide sequences</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=protein&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_protein&amp;IdsFromResult=3186311" ref="reftype=Protein&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Protein&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Protein</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-25" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Protein<div class="brieflinkpopdesc">Published protein sequences</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pubmed/21659360/" ref="reftype=PubMed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|PubMed|Record&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">PubMed</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-26" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">PubMed<div class="brieflinkpopdesc">PubMed citations for these articles</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=snp&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_snp&amp;IdsFromResult=3186311" ref="reftype=SNP&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|SNP&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">SNP</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-27" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">SNP<div class="brieflinkpopdesc">PMC to SNP links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=pcsubstance&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_pcsubstance&amp;IdsFromResult=3186311" ref="reftype=Substance&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|PubChem%20Substance&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Substance</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-28" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Substance<div class="brieflinkpopdesc">PubChem Substance links</div>
</div>
</li>
<li class="brieflinkpopper">
<a class="brieflinkpopperctrl" href="/pmc/?Db=taxonomy&amp;DbFrom=pmc&amp;Cmd=Link&amp;LinkName=pmc_taxonomy&amp;IdsFromResult=3186311" ref="reftype=Taxonomy&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|DiscoveryLinks&amp;TO=Entrez|Crosslink|Taxonomy&amp;rendering-type=normal" role="button" aria-expanded="false" aria-haspopup="true">Taxonomy</a><div class="brieflinkpop ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" id="ui-brieflinkpop-29" aria-live="assertive" aria-hidden="true" style="top: -100px; left: -100px; display: none;">Taxonomy<div class="brieflinkpopdesc">Related taxonomy entry</div>
</div>
</li>
</ul></div></div>
</div><div class="portlet">
<div class="portlet_head">
<div class="portlet_title"><h3><span>Recent Activity</span></h3></div>
<a name="Shutter" sid="1" href="#" class="portlet_shutter shutter_closed ui-ncbitoggler" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" toggles="ui-portlet_content-30" role="button" aria-expanded="false" style="position: absolute; padding: 0px;"></a>
</div>
<div class="ui-helper-reset" aria-live="assertive"><div class="portlet_content ui-ncbitoggler ui-ncbitoggler-slave" style="display: none;" id="ui-portlet_content-30" aria-hidden="true"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class="">
<div class="action">
<a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a>
</div>
<ul id="activity">
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dd52d6d39a66eb03dc9a772">Association between single nucleotide polymorphism-genotype and outcome of patie...</a><div class="ralinkpop offscreen_noflow">Association between single nucleotide polymorphism-genotype and outcome of patients with chronic lymphocytic leukemia in a randomized chemotherapy trial<div class="brieflinkpopdesc">Haematologica. 2011 Oct; 96(10)1496</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=5dd52d46dd2142621dab8888">Genome-wide association study of severity in multiple sclerosis</a><div class="ralinkpop offscreen_noflow">Genome-wide association study of severity in multiple sclerosis<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2011 Dec; 12(8)615</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=5dd52d1639a66eb03dbbf3b5">Genome-wide Association with C-Reactive Protein Levels in CLHNS: Evidence for th...</a><div class="ralinkpop offscreen_noflow">Genome-wide Association with C-Reactive Protein Levels in CLHNS: Evidence for the CRP and HNF1A Loci and their Interaction with exposure to a pathogenic environment<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2012 Apr; 35(2)574</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=5dd52cfa39a66eb03db7ac90">Genome-wide association and meta-analysis in populations from Starr County, Texa...</a><div class="ralinkpop offscreen_noflow">Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals<div class="brieflinkpopdesc">NIHPA Author Manuscripts. 2011 Aug; 54(8)2047</div>
</div>
<div class="tertiary"></div>
</li>
<li class="ra_rcd ralinkpopper two_line">
<a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=5dd52cd0dde0893a8bcd041b">Mayo Genome Consortia: A Genotype-Phenotype Resource for Genome-Wide Association...</a><div class="ralinkpop offscreen_noflow">Mayo Genome Consortia: A Genotype-Phenotype Resource for Genome-Wide Association Studies With an Application to the Analysis of Circulating Bilirubin Levels<div class="brieflinkpopdesc">Mayo Clinic Proceedings. 2011 Jul; 86(7)606</div>
</div>
<div class="tertiary"></div>
</li>
</ul>
<p class="HTOn">Your browsing activity is empty.</p>
<p class="HTOff">Activity recording is turned off.</p>
<p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p>
<a class="seemore" href="/sites/myncbi/recentactivity">See more...</a>
</div></div></div>
</div>
<div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p6" name="crb--__p6" rid="__p6" style="position: absolute; visibility: visible; width: 370px; top: 1217px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-31"><ul>
<li class="two_line" reference_id="b1-0961496">
<a href="/pubmed/14962897/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Chronic lymphocytic leukemia: revelations from the B-cell receptor.</a><span class="one_line_source">[Blood.  2004]</span><div class="alt-note">
<div class="authors">Stevenson FK, Caligaris-Cappio F</div>
<div class="citation">Blood. 2004 Jun 15; 103(12):4389-95.</div>
</div>
</li>
<li class="two_line" reference_id="b2-0961496">
<a href="/pubmed/17389762/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).</a><span class="one_line_source">[Blood.  2007]</span><div class="alt-note">
<div class="authors">Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD</div>
<div class="citation">Blood. 2007 Jul 15; 110(2):695-708.</div>
</div>
</li>
<li class="two_line" reference_id="b3-0961496">
<a href="/pubmed/10907482/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Prognostic factors in chronic lymphocytic leukaemia.</a><span class="one_line_source">[Haematologica.  1999]</span><div class="alt-note">
<div class="authors">Binet JL</div>
<div class="citation">Haematologica. 1999 Jun; 84 Suppl EHA-4():96-7.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p7" name="crb--__p7" rid="__p7" style="position: absolute; visibility: visible; width: 370px; top: 1361px; display: none;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-32"><ul>
<li class="two_line" reference_id="b4-0961496">
<a href="/pubmed/11136261/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genomic aberrations and survival in chronic lymphocytic leukemia.</a><span class="one_line_source">[N Engl J Med.  2000]</span><div class="alt-note">
<div class="authors">Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, Döhner K, Bentz M, Lichter P</div>
<div class="citation">N Engl J Med. 2000 Dec 28; 343(26):1910-6.</div>
</div>
</li>
<li class="two_line" reference_id="b6-0961496">
<a href="/pubmed/11675331/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Clinical significance of CD38 expression in chronic lymphocytic leukemia.</a><span class="one_line_source">[Blood.  2001]</span><div class="alt-note">
<div class="authors">Del Poeta G, Maurillo L, Venditti A, Buccisano F, Epiceno AM, Capelli G, Tamburini A, Suppo G, Battaglia A, Del Principe MI, Del Moro B, Masi M, Amadori S</div>
<div class="citation">Blood. 2001 Nov 1; 98(9):2633-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p8" name="crb--__p8" rid="__p8" style="position: absolute; visibility: visible; width: 370px; top: 1571px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-33"><ul>
<li class="two_line" reference_id="b7-0961496">
<a href="/pubmed/18758461/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.</a><span class="one_line_source">[Nat Genet.  2008]</span><div class="alt-note">
<div class="authors">Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R, Sullivan K, Vijayakrishnan J, Wang Y, Pittman AM, Sunter NJ, Hall AG, Dyer MJ, Matutes E, Dearden C, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Hillmen P, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Allan JM, Catovsky D, Houlston RS</div>
<div class="citation">Nat Genet. 2008 Oct; 40(10):1204-10.</div>
</div>
</li>
<li class="two_line" reference_id="b8-0961496">
<a href="/pubmed/20062064/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.</a><span class="one_line_source">[Nat Genet.  2010]</span><div class="alt-note">
<div class="authors">Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, Mansouri M, Ruiz-Ponte C, Enjuanes A, Rosenquist R, Carracedo A, Jurlander J, Campo E, Juliusson G, Montserrat E, Smedby KE, Dyer MJ, Matutes E, Dearden C, Sunter NJ, Hall AG, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Parker A, Oscier D, Allan JM, Catovsky D, Houlston RS</div>
<div class="citation">Nat Genet. 2010 Feb; 42(2):132-6.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p9" name="crb--__p9" rid="__p9" style="position: absolute; visibility: visible; width: 370px; top: 1752px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-34"><ul><li class="two_line" reference_id="b9-0961496">
<a href="/pubmed/17658394/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.</a><span class="one_line_source">[Lancet.  2007]</span><div class="alt-note">
<div class="authors">Catovsky D, Richards S, Matutes E, Oscier D, Dyer M, Bezares RF, Pettitt AR, Hamblin T, Milligan DW, Child JA, Hamilton MS, Dearden CE, Smith AG, Bosanquet AG, Davis Z, Brito-Babapulle V, Else M, Wade R, Hillmen P, UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group., NCRI Chronic Lymphocytic Leukaemia Working Group.</div>
<div class="citation">Lancet. 2007 Jul 21; 370(9583):230-239.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p12" name="crb--__p12" rid="__p12" style="position: absolute; visibility: visible; width: 370px; top: 2285px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-35"><ul><li class="two_line" reference_id="b7-0961496">
<a href="/pubmed/18758461/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.</a><span class="one_line_source">[Nat Genet.  2008]</span><div class="alt-note">
<div class="authors">Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R, Sullivan K, Vijayakrishnan J, Wang Y, Pittman AM, Sunter NJ, Hall AG, Dyer MJ, Matutes E, Dearden C, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Hillmen P, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Allan JM, Catovsky D, Houlston RS</div>
<div class="citation">Nat Genet. 2008 Oct; 40(10):1204-10.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p14" name="crb--__p14" rid="__p14" style="position: absolute; visibility: visible; width: 370px; top: 2917px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-36"><ul>
<li class="two_line" reference_id="b10-0961496">
<a href="/pubmed/12202775/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Human non-synonymous SNPs: server and survey.</a><span class="one_line_source">[Nucleic Acids Res.  2002]</span><div class="alt-note">
<div class="authors">Ramensky V, Bork P, Sunyaev S</div>
<div class="citation">Nucleic Acids Res. 2002 Sep 1; 30(17):3894-900.</div>
</div>
</li>
<li class="two_line" reference_id="b11-0961496">
<a href="/pubmed/11337480/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Predicting deleterious amino acid substitutions.</a><span class="one_line_source">[Genome Res.  2001]</span><div class="alt-note">
<div class="authors">Ng PC, Henikoff S</div>
<div class="citation">Genome Res. 2001 May; 11(5):863-74.</div>
</div>
</li>
<li class="two_line" reference_id="b12-0961496">
<a href="/pubmed/15177551/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function.</a><span class="one_line_source">[Genomics.  2004]</span><div class="alt-note">
<div class="authors">Xi T, Jones IM, Mohrenweiser HW</div>
<div class="citation">Genomics. 2004 Jun; 83(6):970-9.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p15" name="crb--__p15" rid="__p15" style="position: absolute; visibility: visible; width: 370px; top: 3169px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-37"><ul>
<li class="two_line" reference_id="b13-0961496">
<a href="/pubmed/16362079/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Genome-wide associations of gene expression variation in humans.</a><span class="one_line_source">[PLoS Genet.  2005]</span><div class="alt-note">
<div class="authors">Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R, Hunt S, Kahl B, Antonarakis SE, Tavaré S, Deloukas P, Dermitzakis ET</div>
<div class="citation">PLoS Genet. 2005 Dec; 1(6):e78.</div>
</div>
</li>
<li class="two_line" reference_id="b14-0961496">
<a href="/pubmed/17289997/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Relative impact of nucleotide and copy number variation on gene expression phenotypes.</a><span class="one_line_source">[Science.  2007]</span><div class="alt-note">
<div class="authors">Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, Tyler-Smith C, Carter N, Scherer SW, Tavaré S, Deloukas P, Hurles ME, Dermitzakis ET</div>
<div class="citation">Science. 2007 Feb 9; 315(5813):848-53.</div>
</div>
</li>
<li class="two_line" reference_id="b15-0961496">
<a href="/pubmed/3992076/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A Wilcoxon-type test for trend.</a><span class="one_line_source">[Stat Med.  1985]</span><div class="alt-note">
<div class="authors">Cuzick J</div>
<div class="citation">Stat Med. 1985 Jan-Mar; 4(1):87-90.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p19" name="crb--__p19" rid="__p19" style="position: absolute; visibility: visible; width: 370px; top: 4598px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-38"><ul><li class="two_line" reference_id="b16-0961496">
<a href="/pubmed/16228001/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Population structure, differential bias and genomic control in a large-scale, case-control association study.</a><span class="one_line_source">[Nat Genet.  2005]</span><div class="alt-note">
<div class="authors">Clayton DG, Walker NM, Smyth DJ, Pask R, Cooper JD, Maier LM, Smink LJ, Lam AC, Ovington NR, Stevens HE, Nutland S, Howson JM, Faham M, Moorhead M, Jones HB, Falkowski M, Hardenbol P, Willis TD, Todd JA</div>
<div class="citation">Nat Genet. 2005 Nov; 37(11):1243-6.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p23" name="crb--__p23" rid="__p23" style="position: absolute; visibility: visible; width: 370px; top: 6354px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-39"><ul><li class="two_line" reference_id="b17-0961496">
<a href="/pubmed/19008095/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.</a><span class="one_line_source">[Eur J Cancer.  2009]</span><div class="alt-note">
<div class="authors">Brendle A, Brandt A, Johansson R, Enquist K, Hallmans G, Hemminki K, Lenner P, Försti A</div>
<div class="citation">Eur J Cancer. 2009 Feb; 45(3):435-42.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p26" name="crb--__p26" rid="__p26" style="position: absolute; visibility: visible; width: 370px; top: 7804px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-40"><ul>
<li class="two_line" reference_id="b18-0961496">
<a href="/pubmed/19224852/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment.</a><span class="one_line_source">[J Clin Oncol.  2009]</span><div class="alt-note">
<div class="authors">Wierda WG, O'Brien S, Wang X, Faderl S, Ferrajoli A, Do KA, Garcia-Manero G, Cortes J, Thomas D, Koller C, Burger J, Lerner S, Kantarjian H, Keating M</div>
<div class="citation">J Clin Oncol. 2009 Apr 1; 27(10):1637-43.</div>
</div>
</li>
<li class="two_line" reference_id="b19-0961496">
<a href="/pubmed/20511662/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation.</a><span class="one_line_source">[Haematologica.  2010]</span><div class="alt-note">
<div class="authors">Oscier D, Wade R, Davis Z, Morilla A, Best G, Richards S, Else M, Matutes E, Catovsky D, Chronic Lymphocytic Leukaemia Working Group, UK National Cancer Research Institute.</div>
<div class="citation">Haematologica. 2010 Oct; 95(10):1705-12.</div>
</div>
</li>
</ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p27" name="crb--__p27" rid="__p27" style="position: absolute; visibility: visible; width: 370px; top: 8173px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-41"><ul><li class="two_line" reference_id="b20-0961496">
<a href="/pubmed/16038780/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Identification of progression markers in B-CLL by gene expression profiling.</a><span class="one_line_source">[Exp Hematol.  2005]</span><div class="alt-note">
<div class="authors">Fält S, Merup M, Gahrton G, Lambert B, Wennborg A</div>
<div class="citation">Exp Hematol. 2005 Aug; 33(8):883-93.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p29" name="crb--__p29" rid="__p29" style="position: absolute; visibility: visible; width: 370px; top: 9173px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-42"><ul><li class="two_line" reference_id="b21-0961496">
<a href="/pubmed/17908822/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Altered adenosine-to-inosine RNA editing in human cancer.</a><span class="one_line_source">[Genome Res.  2007]</span><div class="alt-note">
<div class="authors">Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M, Hirschberg A, Krupsky M, Ben-Dov I, Cazacu S, Mikkelsen T, Brodie C, Eisenberg E, Rechavi G</div>
<div class="citation">Genome Res. 2007 Nov; 17(11):1586-95.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p33" name="crb--__p33" rid="__p33" style="position: absolute; visibility: visible; width: 370px; top: 9461px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-43"><ul><li class="two_line" reference_id="b22-0961496">
<a href="/pubmed/18256281/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A novel Cas family member, HEPL, regulates FAK and cell spreading.</a><span class="one_line_source">[Mol Biol Cell.  2008]</span><div class="alt-note">
<div class="authors">Singh MK, Dadke D, Nicolas E, Serebriiskii IG, Apostolou S, Canutescu A, Egleston BL, Golemis EA</div>
<div class="citation">Mol Biol Cell. 2008 Apr; 19(4):1627-36.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p34" name="crb--__p34" rid="__p34" style="position: absolute; visibility: visible; width: 370px; top: 9627px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-44"><ul><li class="two_line" reference_id="b7-0961496">
<a href="/pubmed/18758461/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.</a><span class="one_line_source">[Nat Genet.  2008]</span><div class="alt-note">
<div class="authors">Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R, Sullivan K, Vijayakrishnan J, Wang Y, Pittman AM, Sunter NJ, Hall AG, Dyer MJ, Matutes E, Dearden C, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Hillmen P, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Allan JM, Catovsky D, Houlston RS</div>
<div class="citation">Nat Genet. 2008 Oct; 40(10):1204-10.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p40" name="crb--__p40" rid="__p40" style="position: absolute; visibility: visible; width: 370px; top: 10619px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-45"><ul><li class="two_line" reference_id="b17-0961496">
<a href="/pubmed/19008095/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.</a><span class="one_line_source">[Eur J Cancer.  2009]</span><div class="alt-note">
<div class="authors">Brendle A, Brandt A, Johansson R, Enquist K, Hallmans G, Hemminki K, Lenner P, Försti A</div>
<div class="citation">Eur J Cancer. 2009 Feb; 45(3):435-42.</div>
</div>
</li></ul></div>
</div>
<div class="portlet brieflink pmc_para_cit" id="crb--__p42" name="crb--__p42" rid="__p42" style="position: absolute; visibility: visible; width: 370px; top: 11105px;">
<div class="portlet_head"></div>
<div class="portlet_content" id="ui-portlet_content-46"><ul>
<li class="two_line" reference_id="b23-0961496">
<a href="/pubmed/17575498/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Non-replication of association studies: "pseudo-failures" to replicate?</a><span class="one_line_source">[Genet Med.  2007]</span><div class="alt-note">
<div class="authors">Gorroochurn P, Hodge SE, Heiman GA, Durner M, Greenberg DA</div>
<div class="citation">Genet Med. 2007 Jun; 9(6):325-31.</div>
</div>
</li>
<li class="two_line" reference_id="b24-0961496">
<a href="/pubmed/17426274/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal"><span class="invert">Review</span> Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study.</a><span class="one_line_source">[JAMA.  2007]</span><div class="alt-note">
<div class="authors">Morgan TM, Krumholz HM, Lifton RP, Spertus JA</div>
<div class="citation">JAMA. 2007 Apr 11; 297(14):1551-61.</div>
</div>
</li>
</ul></div>
</div>
</div>   
    </div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"><div id="body-link-popper-b1-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Chronic lymphocytic leukemia: revelations from the B-cell receptor.<div class="authors">Stevenson FK, Caligaris-Cappio F</div><div class="citation">Blood. 2004 Jun 15; 103(12):4389-95.</div><p>[<a href="/pubmed/14962897/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b1-0961496">Ref list</a>]</p></div><div id="body-link-popper-b2-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).<div class="authors">Morton LM, Turner JJ, Cerhan JR, Linet MS, Treseler PA, Clarke CA, Jack A, Cozen W, Maynadié M, Spinelli JJ, Costantini AS, Rüdiger T, Scarpa A, Zheng T, Weisenburger DD</div><div class="citation">Blood. 2007 Jul 15; 110(2):695-708.</div><p>[<a href="/pubmed/17389762/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b2-0961496">Ref list</a>]</p></div><div id="body-link-popper-b3-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Prognostic factors in chronic lymphocytic leukaemia.<div class="authors">Binet JL</div><div class="citation">Haematologica. 1999 Jun; 84 Suppl EHA-4():96-7.</div><p>[<a href="/pubmed/10907482/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b3-0961496">Ref list</a>]</p></div><div id="body-link-popper-b4-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Genomic aberrations and survival in chronic lymphocytic leukemia.<div class="authors">Döhner H, Stilgenbauer S, Benner A, Leupolt E, Kröber A, Bullinger L, Döhner K, Bentz M, Lichter P</div><div class="citation">N Engl J Med. 2000 Dec 28; 343(26):1910-6.</div><p>[<a href="/pubmed/11136261/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b4-0961496">Ref list</a>]</p></div><div id="body-link-popper-b6-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Clinical significance of CD38 expression in chronic lymphocytic leukemia.<div class="authors">Del Poeta G, Maurillo L, Venditti A, Buccisano F, Epiceno AM, Capelli G, Tamburini A, Suppo G, Battaglia A, Del Principe MI, Del Moro B, Masi M, Amadori S</div><div class="citation">Blood. 2001 Nov 1; 98(9):2633-9.</div><p>[<a href="/pubmed/11675331/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b6-0961496">Ref list</a>]</p></div><div id="body-link-popper-b7-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.<div class="authors">Di Bernardo MC, Crowther-Swanepoel D, Broderick P, Webb E, Sellick G, Wild R, Sullivan K, Vijayakrishnan J, Wang Y, Pittman AM, Sunter NJ, Hall AG, Dyer MJ, Matutes E, Dearden C, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Hillmen P, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Allan JM, Catovsky D, Houlston RS</div><div class="citation">Nat Genet. 2008 Oct; 40(10):1204-10.</div><p>[<a href="/pubmed/18758461/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b7-0961496">Ref list</a>]</p></div><div id="body-link-popper-b8-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk.<div class="authors">Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, Mansouri M, Ruiz-Ponte C, Enjuanes A, Rosenquist R, Carracedo A, Jurlander J, Campo E, Juliusson G, Montserrat E, Smedby KE, Dyer MJ, Matutes E, Dearden C, Sunter NJ, Hall AG, Mainou-Fowler T, Jackson GH, Summerfield G, Harris RJ, Pettitt AR, Allsup DJ, Bailey JR, Pratt G, Pepper C, Fegan C, Parker A, Oscier D, Allan JM, Catovsky D, Houlston RS</div><div class="citation">Nat Genet. 2010 Feb; 42(2):132-6.</div><p>[<a href="/pubmed/20062064/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b8-0961496">Ref list</a>]</p></div><div id="body-link-popper-b9-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial.<div class="authors">Catovsky D, Richards S, Matutes E, Oscier D, Dyer M, Bezares RF, Pettitt AR, Hamblin T, Milligan DW, Child JA, Hamilton MS, Dearden CE, Smith AG, Bosanquet AG, Davis Z, Brito-Babapulle V, Else M, Wade R, Hillmen P, UK National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group., NCRI Chronic Lymphocytic Leukaemia Working Group.</div><div class="citation">Lancet. 2007 Jul 21; 370(9583):230-239.</div><p>[<a href="/pubmed/17658394/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b9-0961496">Ref list</a>]</p></div><div id="body-link-popper-b10-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Human non-synonymous SNPs: server and survey.<div class="authors">Ramensky V, Bork P, Sunyaev S</div><div class="citation">Nucleic Acids Res. 2002 Sep 1; 30(17):3894-900.</div><p>[<a href="/pubmed/12202775/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b10-0961496">Ref list</a>]</p></div><div id="body-link-popper-b11-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Predicting deleterious amino acid substitutions.<div class="authors">Ng PC, Henikoff S</div><div class="citation">Genome Res. 2001 May; 11(5):863-74.</div><p>[<a href="/pubmed/11337480/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b11-0961496">Ref list</a>]</p></div><div id="body-link-popper-b12-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function.<div class="authors">Xi T, Jones IM, Mohrenweiser HW</div><div class="citation">Genomics. 2004 Jun; 83(6):970-9.</div><p>[<a href="/pubmed/15177551/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b12-0961496">Ref list</a>]</p></div><div id="body-link-popper-b13-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Genome-wide associations of gene expression variation in humans.<div class="authors">Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R, Hunt S, Kahl B, Antonarakis SE, Tavaré S, Deloukas P, Dermitzakis ET</div><div class="citation">PLoS Genet. 2005 Dec; 1(6):e78.</div><p>[<a href="/pubmed/16362079/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b13-0961496">Ref list</a>]</p></div><div id="body-link-popper-b14-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Relative impact of nucleotide and copy number variation on gene expression phenotypes.<div class="authors">Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, Tyler-Smith C, Carter N, Scherer SW, Tavaré S, Deloukas P, Hurles ME, Dermitzakis ET</div><div class="citation">Science. 2007 Feb 9; 315(5813):848-53.</div><p>[<a href="/pubmed/17289997/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b14-0961496">Ref list</a>]</p></div><div id="body-link-popper-b15-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A Wilcoxon-type test for trend.<div class="authors">Cuzick J</div><div class="citation">Stat Med. 1985 Jan-Mar; 4(1):87-90.</div><p>[<a href="/pubmed/3992076/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b15-0961496">Ref list</a>]</p></div><div id="body-link-popper-b16-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Population structure, differential bias and genomic control in a large-scale, case-control association study.<div class="authors">Clayton DG, Walker NM, Smyth DJ, Pask R, Cooper JD, Maier LM, Smink LJ, Lam AC, Ovington NR, Stevens HE, Nutland S, Howson JM, Faham M, Moorhead M, Jones HB, Falkowski M, Hardenbol P, Willis TD, Todd JA</div><div class="citation">Nat Genet. 2005 Nov; 37(11):1243-6.</div><p>[<a href="/pubmed/16228001/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b16-0961496">Ref list</a>]</p></div><div id="body-link-popper-b17-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Single nucleotide polymorphisms in chromosomal instability genes and risk and clinical outcome of breast cancer: a Swedish prospective case-control study.<div class="authors">Brendle A, Brandt A, Johansson R, Enquist K, Hallmans G, Hemminki K, Lenner P, Försti A</div><div class="citation">Eur J Cancer. 2009 Feb; 45(3):435-42.</div><p>[<a href="/pubmed/19008095/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b17-0961496">Ref list</a>]</p></div><div id="body-link-popper-b18-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment.<div class="authors">Wierda WG, O'Brien S, Wang X, Faderl S, Ferrajoli A, Do KA, Garcia-Manero G, Cortes J, Thomas D, Koller C, Burger J, Lerner S, Kantarjian H, Keating M</div><div class="citation">J Clin Oncol. 2009 Apr 1; 27(10):1637-43.</div><p>[<a href="/pubmed/19224852/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b18-0961496">Ref list</a>]</p></div><div id="body-link-popper-b19-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Prognostic factors identified three risk groups in the LRF CLL4 trial, independent of treatment allocation.<div class="authors">Oscier D, Wade R, Davis Z, Morilla A, Best G, Richards S, Else M, Matutes E, Catovsky D, Chronic Lymphocytic Leukaemia Working Group, UK National Cancer Research Institute.</div><div class="citation">Haematologica. 2010 Oct; 95(10):1705-12.</div><p>[<a href="/pubmed/20511662/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b19-0961496">Ref list</a>]</p></div><div id="body-link-popper-b20-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Identification of progression markers in B-CLL by gene expression profiling.<div class="authors">Fält S, Merup M, Gahrton G, Lambert B, Wennborg A</div><div class="citation">Exp Hematol. 2005 Aug; 33(8):883-93.</div><p>[<a href="/pubmed/16038780/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b20-0961496">Ref list</a>]</p></div><div id="body-link-popper-b21-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">Altered adenosine-to-inosine RNA editing in human cancer.<div class="authors">Paz N, Levanon EY, Amariglio N, Heimberger AB, Ram Z, Constantini S, Barbash ZS, Adamsky K, Safran M, Hirschberg A, Krupsky M, Ben-Dov I, Cazacu S, Mikkelsen T, Brodie C, Eisenberg E, Rechavi G</div><div class="citation">Genome Res. 2007 Nov; 17(11):1586-95.</div><p>[<a href="/pubmed/17908822/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b21-0961496">Ref list</a>]</p></div><div id="body-link-popper-b22-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true">A novel Cas family member, HEPL, regulates FAK and cell spreading.<div class="authors">Singh MK, Dadke D, Nicolas E, Serebriiskii IG, Apostolou S, Canutescu A, Egleston BL, Golemis EA</div><div class="citation">Mol Biol Cell. 2008 Apr; 19(4):1627-36.</div><p>[<a href="/pubmed/18256281/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b22-0961496">Ref list</a>]</p></div><div id="body-link-popper-b23-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Non-replication of association studies: "pseudo-failures" to replicate?<div class="authors">Gorroochurn P, Hodge SE, Heiman GA, Durner M, Greenberg DA</div><div class="citation">Genet Med. 2007 Jun; 9(6):325-31.</div><p>[<a href="/pubmed/17575498/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b23-0961496">Ref list</a>]</p></div><div id="body-link-popper-b24-0961496" class="body-link-popper ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic" style="display: none; width: 30em; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true"><span class="invert">Review</span> Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study.<div class="authors">Morgan TM, Krumholz HM, Lifton RP, Spertus JA</div><div class="citation">JAMA. 2007 Apr 11; 297(14):1551-61.</div><p>[<a href="/pubmed/17426274/" ref="reftype=pubmed&amp;article-id=3186311&amp;issue-id=200717&amp;journal-id=820&amp;FROM=Article|CitedRefBlock&amp;TO=Entrez|Pubmed|Record&amp;rendering-type=normal">PubMed</a>] [<a href="#b24-0961496">Ref list</a>]</p></div></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T07:11:25-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE89F792DD524231000000000689043F&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3186311%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=haematol&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3186311/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>